Year 2020 Vol. 28 No 5




432 Main Military Clinical Medical Center of the Armed Forces of the Republic of Belarus 1
Belorussian State Medical University 2, Minsk,
The Republic of Belarus

Objective. To evaluate the effectiveness of intraperitoneal and intramuscular administration of methylethylpyridinol hydrochloride (emoxypine) for traumatic injuries of the extremity muscles.
Methods. The studies were carried out on the white outbred rats (n=32). After the experimental animals were subjected to the ether anesthesia, the destruction of the striated muscles was achieved by compressing the gastrocnemius muscle in its middle third using a needle holder. 1 hour after the injury all animals underwent fasciotomy of the injured limb segment, anesthesia and emoxypine administration. The animals were divided into 4 groups (n=8 per group). To the first and third groups emoxypine was administered daily intraperitoneally once day, the second and fourth groups intramuscularly (paravulnary into the gastrocnemius muscle). The first and second groups of animals were withdrawn from the experiment on the third day, the third and fourth on the gerenth day. Subsequently, material was taken for the research, paraffin blocks were prepared and sections were made with hematoxylin and eosin staining. The assessment of morphological changes was carried out using the index of morphological changes in muscles.
Results. When assessing the severity of cell infiltration on the third day, statistically significant differences were determined in animals of the first and second groups for this indicator (U=11.5, p=0.0357). The index of morphological changes in muscles in the fourth group was 3.0 (2.5; 4.0) and significantly differed from the second (8.0 (6.0; 9.0); U=5.5, p=0, 0063). On the seventh day, the animals of the third and fourth groups also showed statistically significant differences (U=4.5, p=0.0046) in favor of intramuscular administration. Thus, on the third day with intramuscular administration of emoxypine, more pronounced cellular infiltration and less pronounced necrotic changes in the wound on the seventh day are observed, which leads to a faster wound process as a whole healing.
Conclusion. Intramuscular administration of emoxypine has a more pronounced therapeutic effect in traumatic injuries of limb muscles compared with intraperitoneal administration.

Keywords: muscle injury, antihypoxants, wound healing, reactive oxygen species, oxidative stress
p. 491-497 of the original issue
  1. Minasov T B, Faizullin AA, Saubanov RA, Minasov IB. Efficiency of structural antigipoxants in perioperative period of patients with lower limbs fractures
    Hirurgija Zhurn im NI Pirogova. 2018;(9):67-72. doi: 10.17116/hirurgia2018090168 (In Russ.)
  2. Didenko OA, Byalik EI, Ivanov PA, Sokolov VA, Tsoglin LL. Treatment of traumatic avulsions of extremities in patients with polytrauma. Politravma. 2010;(4):17-23. (In Russ.)
  3. Denk S, Weckbach S, Eisele P, Braun CK, Wiegner R, Ohmann JJ, Wrba L, Hoenes FM, Kellermann P, Radermacher P, Wachter U, Hafner S, McCook O, Schultze A, Palmer A, Braumüller S, Gebhard F, Huber-Lang M. Role of hemorrhagic shock in experimental polytrauma. Shock. 2018 Feb;49(2):154-63. doi: 10.1097/SHK.0000000000000925
  4. Repine J, Parsons P. Oxidant-antioxidant balance in endotoxine-induced oxidative injury and tolerance to oxidative injury. Endotoxine and the lung. 1994. p. 207-17.
  5. Usenko LV, Tsariov OV. Modern opportunities of energy protection in critical states. Medicina Neotlozhnyh Sostojanij. 2016;4(75):72-78. doi: 10.22141/2224-0586.4.75.2016.75820 (In Russ.)
  6. Ivkin DJu, Okovityj SV. Patogeneticheskaja terapija sostojanij gipoksii organov i tkanej na kletochnom urovne. Lechashhij Vrach. 2017;2(7):11-16. (In Russ.)
  7. Korshunova GA, Shishkina AV, Skulachev MV. Design, synthesis and some aspects of biological activity of mitochondria-targeted antioxidants. Biohimija. 2017;82(7):998-17. (In Russ.)
  8. Li C, Jackson R. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. AJP: Cell Physiology. 2002;282(2):227-41. doi: 10.1152/ajpcell.00112.2001
  9. Okovity SV, Sukhanov DS, Zaplutanov VA, Smagina AN. Antihypoxants in current clinical practice. Klin Medicina. 2012;90(9):63-68. (In Russ.)
  10. Ivancova VA, Kravcov SN, Sidelnikov VO, Shilovich VA. Rol infuzionnyh antigipoksantov v kompleksnom lechenii jendotoksikoza pri tjazhjolyh travmah i kombinirovannyh ozhogovyh porazhenijah. Vestn Ros VMA. 2007;(2):123-26. (In Russ.)
  11. Levchenkova OS, Novikov VE, Pozhilova YeV. Pharmacodynamics of antihypoxants and their clinical use. Obzory po Klin Farmakologii i Lekarstv Terapii. 2012;10(3):3-12. (In Russ.)
  12. Novikov VE, Levchenkova OS, Ivancova EN. Perspektivy primenenija antigipoksantov v lechenii mitohondrialnyh disfunkcij. Vestn SmGMA. 2020;19(1):41-55. (In Russ.)
  13. Trukhan AP, Zhidkov SA, Letkovskaya TA. Complex assessment of effectiveness of paravulnar intramuscular administration of antihypoxic drugs in case of muscle gunshot wounds. Voen-Med Zhurn. 2017;338(1):34-38. (In Russ.)
  14. Glanc S. Mediko-biologicheskaja statistika. Per. s angl. Moscow, RF: Praktika; 1998. 459 p. (In Russ.)
  15. Novikov VE, Losenkova SO. Farmakalogija proizvodnyh 3-oksipiridina. Obzory po Klin Farmakalogii i Lekarstv Terapii. 2004;3(1):2-14.
Address for correspondence:
220034, Republic of Belarus,
Minsk, Azgur str., 4,
Belorussian State Medical University,
the Military Medical Faculty,
mobile tel.: 8-029-776-91-06,,
Tereshko Dmitry G.
Information about the authors:
Trukhan Alexey P., PhD, Associate Professor, Leading Surgeon of the Medical Unit of 432 Main Military Clinical Medical Center of the Armed Forces of the Republic of Belarus, Minsk, Republic of Belarus.
Tereshko Dmitry G., Assistant of the Military Field Surgery of the Military Medical Faculty, the Military Medical Faculty, Belorussian State Medical University, Minsk, Republic of Belarus.
Letkovskaya Tatyana A., PhD, Associate Professor, Head of the Pathologic Anatomy Department, Belorussian State Medical University, Minsk, Republic of Belarus.



Voronezh State Medical University named after N.N. Burdenko, Voronezh,
Russian Federation

Objective. Assessment of the possibility to use the developed spacer device while treating infectious complications after the hip replacement surgery.
Methods. The hip spacer has been developed to improve the outcomes of periprosthetic infection treatment. The spacer consists of the head, neck and a stem, made of bone cement. The carcass connected with the micropump is located inside it. The carcass is made in the form of four metal tubes which hold a liquid solution of drugs. The pump pistons are made of ferromagnet to interact with a magnet brought to the surface of the body. Drugs are released from the spacer under the external manetic field exposure in the postoperative period. The working spacer model was developed on the basis of the department of traumatology and orthopedics of Voronezh State Medical University named after N.N. Burdenko. Experimental studies on rabbits were conducted to evaluate the functionality of the spacer device. An implant containing Pyrogenalum solution was inserted in the abdominal cavity of animals under the intravenous anesthesia. In the test group the average temperature was estimated prior to and after the introduction of Pyrogenalum (under the magnetic field exposure).
Results. The temperature measured after the onset of the spacer operation differed trustworthy from those measured prior to the onset of the experiment (T-test 17.17, p<0.05). This can be explained by the inoculation of Pyrogenalum contained in the spacer into the blood of animals. Experimental studies demonstrated the possibility of drugs release from the spacer into the wound under the magnetic field exposure on the spacer.
Conclusion. The proposed implant allows increasing the volume and quantity of drugs released from it into the wound. Surgeons can non-invasively control the rate of drugs inoculated directly into blood of the periprosthetic space in postoperative period. This provides the required concentration of drugs to help eradicate infection.

Keywords: hip endoprosthesis, periprosthetic infection, bone cement spacer, revision endoprosthesis
p. 498-504 of the original issue
  1. Akhtiamov IF, Kuzmin II. Oshibki i oslozhneniia endoprotezirovaniia tazobedrennogo sustava: ruk dlia vrachei. Kazan, RF: Tsentr operativ. pechati; 2006. 328 p. (In Russ.)
  2. Engesæter LB, Dale H, Schrama JC, Hallan G, Lie SA. Surgical procedures in the treatment of 784 infected THAs reported to the Norwegian Arthroplasty Register. Acta Orthop. 2011 Oct;82(5):530-37. doi: 10.3109/17453674.2011.623572
  3. Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008 Jul;466(7):1710-15. doi: 10.1007/s11999-008-0209-4
  4. Golnik VN, Prokhorenko VM, Pavlov VV. Treatment of early periprosthetic infection at hip replacement. Klin Meditsina. 2012;(4):35-38. (In Russ.)
  5. Eka A, Chen AF. Patient-related medical risk factors for periprosthetic joint infection of the hip and knee. Ann Transl Med. 2015 Sep;3(16):233. doi: 10.3978/j.issn.2305-5839.2015.09.26
  6. Mironov SP, Kotelnikov GP, red. Ortopediia: nats ruk. 2-e izd., pererab. i dop. Moscow, RF: GEOTAR-Media; 2013. 944 p. (In Russ.)
  7. Zubritsky VF, Kozlov YuA. Infectious complications during large joint replacement. Vestn Nats Med-Khirurg Tsentra im NI Pirogova. 2012;7(1):98-103. (In Russ.)
  8. Artiukh VA, Bozhkova SA. Vtoroi etap dvukhetapnogo revizionnogo endoprotezirovaniia. V kn: Artiukh VA, Bozhkova SA, sost. Dvukhetapnoe revizionnoe endoprotezirovanie v lechenii periproteznoi infektsii v oblasti tazobedrennogo sustava: Federalnye klinicheskie rekomendatsii. S-Petersburg, RF; 2015. p. 23-29. In Russ.)
  9. Zagorodnii NV. Endoprotezirovanie tazobedrennogo sustava. Osnovy i praktika: ruk. Moscow, RF: GEOTAR-Media; 2012. 704 p. (In Russ.)
  10. Kuzin MI, Kostiuchenok BM, red. Rany i ranevaia infektsiia: ruk dlia vrachei. Moscow, RF: Meditsina; 1990. 592 p. (In Russ.)
  11. Atıcı T, Şahin N, Çavun S, Özakin C, Kaleli T. Antibiotic release and antibacterial efficacy in cement spacers and cement beads impregnated with different techniques: In vitro study. Eklem Hastalik Cerrahisi. 2018 Aug;29(2):71-78. doi: 10.5606/ehc.2018.59021
  12. Murylev VYu, Kukovenko GA, Elizarov PM, Ivanenko LR, Sorokina GL, Rukin YA, Alekseev SS, Germanov V.G. The first-stage treatment lgorithm for deep infected total hip arthroplasty.Traumatology and Orthopedics of Russia. 2018;24(4):95-104. doi: 10.21823/2311-2905-2018-24-4-95-104 (In Russ.)
  13. Marczak D, Synder M, Sibiński M, Polguj M, Dudka J, Kowalczewski J. Two stage revision hip arthroplasty in periprosthetic joint infection. Comparison study: with or without the use of a spacer. Int Orthop. 2017 Nov;41(11):2253-58. doi: 10.1007/s00264-017-3500-8
  14. Faschingbauer M, Reichel H, Bieger R, Kappe T. Mechanical complications with one hundred and thirty eight (antibiotic-laden) cement spacers in the treatment of periprosthetic infection after total hip arthroplasty. Int Orthop. 2015 May;39(5):989-94. doi: 10.1007/s00264-014-2636-z
  15. van Vugt TAG, Arts JJ, Geurts JAP. Antibiotic-loaded polymethylmethacrylate beads and spacers in treatment of orthopedic infections and the role of biofilm formation. Front Microbiol. 2019 Jul 25;10:1626. doi: 10.3389/fmicb.2019.01626. eCollection 2019.
  16. Samokhin AG, Fedorov EA, Kozlova YN, Tikunova NV, Pavlov VV, Morozova VV, Krclien SO. Application of the lvtic bacteriophages during surgical treatment of the periprosthetic infection of the hip joint endoprosthesis (pilot study). Sovrem Problemy Nauki i Obrazovaniia. 2016;(6):209. (In Russ.)
Address for correspondence:
394036, Russian Federation,
Voronezh, Studencheskaya str., 10,
Voronezh State Medical University
Named after N.N. Burdenko,
the Department of Traumatology and Orthopedics,
tel. +7 4732 57-96-67
Valery G. Samoday
Information about the authors:
Varfolomeev Denis I., Traumatologist-Orthopedist, Attendee of the Department of Traumatology and Orthopedics, Voronezh State Medical University Named after N.N. Burdenko, Voronezh, Russian Federation.
Samoday Valery G., MD, Professor, Head of the Department of Traumatology and Orthopedics, Voronezh State Medical University named after N.N. Burdenko, Voronezh, Russian Federation.




Gomel State Medical University 1,
Gomel Regional Clinical Cardiology Center 2, Gomel,
Republic of Belarus

Objectives. To analyze and assess the efficiency of different strategies of the endovascular revascularization in patients with multilevel affection of lower extremity peripheral arteries based on angiographic and functional criteria.
Methods. The patients (n=114) with chronict multilevel of chronic lower extremity peripheral arteries were included in the study. The first group (n=60) comprised patients who underwent revascularization based on the angiographic criteria; the second one (n=40) included patients in whom the surgery was performed under both angiographic control and invasive intraoperative hemodynamic monitoring of the peripheral circulation; patients of the third group (n=14) were operated on the basis of peripheral fraction blood flow reserve (pFFR) determination in addition to the conventional angiography. Surgery results were assessed depending on value of ankle-brachial index (ABI); to compare the volume of intervention the estimated coefficient of revascularization was expressed as the ratio of the number of the treated segments to the number of affected ones.
Results. In all groups, the performed treatment resulted in the statistically significant (p<0,05) changes of ABI which was the evidence of therapy effectiveness. In the study groups ABI values after the operation amounted 0,8 (0,75; 0,8), 0,9 (0,8; 1) and 0,9 (0,9; 1), respectively, which is associated with a satisfactory result of treatment and prognosis of the disease. The given results were achieved in the presence of the statistically significant difference between groups in length of segments underwent angioplasty (mm) 170 (120; 200), 100 (80; 120) and 130 (115; 155), p=0,00007, stented segment length (mm) 100 (60; 145), 60 (40; 100), 40 (30;40), =0,00063 and revascularization coefficient: 1 (0,67; 1), 0,5 (0,5; 0,66) and 0,5 (0,5; 0,575), p<0,0001.
Conclusion. Methods of invasive functional assessment of the peripheral circulation in addition to the angiographic criteria allow reducing the volume of intervention with an optimal clinical result.

Keywords: chronic lower extremity ischemia, multilevel lesion, revascularization, angiography, hemodynamical monitoring
p. 505-514 of the original issue
  1. Gould KL, Johnson NP, Bateman TM, Beanlands RS, Bengel FM, Bober R, Camici PG, Cerqueira MD, Chow BJW, Di Carli MF, Dorbala S, Gewirtz H, Gropler RJ, Kaufmann PA, Knaapen P, Knuuti J, Merhige ME, Rentrop KP, Ruddy TD, Schelbert HR, Schindler TH, Schwaiger M, Sdringola S, Vitarello J, Williams KA Sr, Gordon D, Dilsizian V, Narula J. Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol. 2013 Oct 29;62(18):1639-53. doi: 10.1016/j.jacc.2013.07.076
  2. Lotfi A, Jeremias A, Fearon WF, Feldman MD, Mehran R, Messenger JC, Grines CL, Dean LS, Kern MJ, Klein LW; Society of Cardiovascular Angiography and Interventions. Expert consensus statement on the use of fractional flow reserve, intravascular ultrasound, and optical coherence tomography: a consensus statement of the Society of Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2014 Mar 1;83(4):509-18. doi: 10.1002/ccd.25222
  3. van de Hoef TP, Meuwissen M, Escaned J, Davies JE, Siebes M, Spaan JA, Piek JJ. Fractional flow reserve as a surrogate for inducible myocardial ischaemia. Nat Rev Cardiol. 2013 Aug;10(8):439-52. doi: 10.1038/nrcardio.2013.86
  4. Xaplanteris P, Fournier S, Pijls NHJ, Fearon WF, Barbato E, Tonino PAL, Engstrøm T, Kääb S, Dambrink JH, Rioufol G, Toth GG, Piroth Z, Witt N, Fröbert O, Kala P, Linke A, Jagic N, Mates M, Mavromatis K, Samady H, Irimpen A, Oldroyd K, Campo G, Rothenbühler M, Jüni P, De Bruyne B; FAME 2 Investigators. Five-year outcomes with pci guided by fractional flow reserve. N Engl J Med. 2018 Jul 19;379(3):250-59. doi: 10.1056/NEJMoa1803538
  5. Pijls NH, Klauss V, Siebert U, Powers E, Takazawa K, Fearon WF, Escaned J, Tsurumi Y, Akasaka T, Samady H, De Bruyne B. Fractional Flow Reserve (FFR) Post-Stent Registry Investigators. Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation. 2002 Jun 25;105(25):2950-54. doi: 10.1161/01.cir.0000020547.92091.76
  6. Murata N, Aihara H, Soga Y, Tomoi Y, Hiramori S, Kobayashi Y, Ichihashi K, Tanaka N. Validation of pressure gradient and peripheral fractional flow reserve measured by a pressure wire for diagnosis of iliofemoral artery disease with intermediate stenosis. Med Devices (Auckl). 2015;8:467-72. Published online 2015 Nov 9. doi: 10.2147/MDER.S83768
  7. Banerjee S, Badhey N, Lichtenwalter C, Varghese C, Brilakis ES. Relationship of walking impairment and ankle-brachial index assessments with peripheral arterial translesional pressure gradients. J Invasive Cardiol. 2011 Sep;23(9):352-56.
  8. Ruzsa Z, Róna S, Tóth GG, Sótonyi P, Bertrand OF, Nemes B, Merkely B, Hüttl K. Fractional flow reserve in below the knee arteries with critical limb ischemia and validation against gold-standard morphologic, functional measures and long term clinical outcomes. Cardiovasc Revasc Med. 2018 Mar;19(2):175-81. doi: 10.1016/j.carrev.2017.07.007
  9. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007 Jan;45(Suppl S):S5-67. doi: 10.1016/j.jvs.2006.12.037
  10. Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I; ESC Scientific Document Group. 2017 ESC Guidelines on the Diagnosis and treatment of peripheral arterial diseases, in collaboration with the european society for vascular surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO) the task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018 Mar 1;39(9):763-16. doi: 10.1093/eurheartj/ehx095
  11. Maeda A, Tashiro K, Sasai M, Mori H, Sato T, Hayashi M, Suzuki H. Safety and efficacy of Adenosine 5-Triphosphate as a hyperemic agent for the assessment of peripheral fractional flow reserve. Showa Univ J Med Sci. 2018;30(2):151-58. doi: 10.15369/sujms.30.151
Address for correspondence:
246046, Republic of Belarus,
Gomel, Meditsinskaya str., 4,
Gomel State Medical University,
Department of Surgical Diseases No1,
Tel./fax: +375 232 49-19-54
Gorokhovsky Sergey Yu.
Information about the authors:
Lyzikov Alexey A., MD, Professor, Head of the Department of Surgical Diseases No1 with the Course of Cardiovascular Surgery, Gomel State Medical University, Gomel, Republic of Belarus.
Gorokhovsky Sergey Yu., Roentgen-Endovascular Surgeon, Head of the Interventional Radiology Ward, Gomel Regional Clinical Cardiology Center, Gomel, Republic of Belarus.
Kaplan Mark L., PhD, Associate Professor of the Department of Surgical Diseases No1 with the Course of Cardiovascular Surgery, Gomel State Medical University, Gomel, Republic of Belarus.
Tihmanovich Victor E., Assistant Lecturer of the Department of Surgical Diseases No1 with the Course of Cardiovascular Surgery, Gomel State Medical University, Gomel, Republic of Belarus.



Moscow Regional Research and Clinical Institute Named after M.F.Vladimirsky 1
M. E. Zhadkevich Moscow City Clinical Hospital of the Department of Health Care of Moscow 2
Moscow Hospital No2 for War Veterans of the Department of Health Care of Moscow 3, Moscow,
The Russian Federation

Objective. To carry out comparative analysis of the results of isolated balloon angioplasty (BA) and BA with stenting of the central venous stenosis (CVS) in patients undergoing hemodialysis .
Methods. A retrospective study included patients (n=62) with CVS. The isolated BA was performed in 39 patients. Stenting was added to isolated BA in 23 patients.
Results. Primary functional patency of the arteriovenous fistula after 1 and 3 years in the BA group was 89.7% [95%CI 74.9; 96] and 30.8% [95%CI 17.3; 45.4]; after stenting: 100% and 30.4% [95%CI 13.5; 49.3]; HR=0.8756 [95%CI 0.527; 1455], p=0.5994. Primary patency after 6 and 12 months in the BA group was 61.5% [95%CI 44.5; 74.7] and 15.4% [95%CI 6.2; 28.3]; after stenting: 82.6% [95%CI 60.1; 93.1] and 47.8% [95%CI 26.8; 66.1]; HR=0.4845 [95%CI 0.2938; 0.799], p=0.0017. Secondary functional patency after 1, 3 and 5 years in the BA group was 100%, 74.4% [95%CI 57.6; 85.3] and 12.8% [95%CI 4.7; 25.2]; after stenting: 100%, 91.3% [95%CI 69.5; 97.8] and 34.8% [95%CI 16.6; 53.7]; HR=0.4764 [95% CI 0.2888; 0.786], p=0.0016. Secondary patency after 6, 12 and 24 months in the BA group was 84.6% [95%CI 68.9; 92.8], 66.7% [95%CI 49.6; 79.1] and 17.9% [95%CI 7.9; 31.3]; after stenting: 91.3% [95%CI 69.5; 97.8], 78.3% [95%CI 55.4; 90.3] and 43.5% [95%CI 23.3; 62.1]; HR=0.4925 [95%CI 0.2988; 0.8119], p=0.0021. Correlation between primary functional patency and primary patency was r= -0.627; p<0.0001, between primary functional patency and secondary patency r= -0.53; p=0.0005 in the BA group; after stenting: r= -0.351; p=0.101 and r= -0.304; p=0.159, respectively.
Conclusion. The results of BA significantly depend on the stage stenosis. The use of stenting can slightly improve the results regardless the CVS terms.

Keywords: vascular access, central veinous stenosis, hemodialysis, chronic kidney disease, endovascular surgery, balloon angioplasty, stenting
p. 515-526 of the original issue
  1. Mansour M, Kamper L, Altenburg A, Haage P. Radiological central vein treatment in vascular access. J Vasc Access. 2008 Apr-Jun;9(2):85-101. doi: 10.1177/112972980800900203
  2. Agarwal AK, Patel BM, Haddad NJ. Central vein stenosis: a nephrologists perspective. Semin Dial. 2007 Jan-Feb;20(1):53-62. doi: 10.1111/j.1525-139X.2007.00242.x
  3. Kundu S. Review of central venous disease in hemodialysis patients. J Vasc Interv Radiol. 2010 Jul;21(7):963-8. doi: 10.1016/j.jvir.2010.01.044
  4. ERA-EDTA Registry: ERA-EDTA Registry Annual Report 2015. Academic Medical Center, Department of Medical Informatics [Internet]. Amsterdam, the Netherlands; 2017. 146 . Available from:
  5. Vatazin AV, Zulkarnaev AB, Fominykh NM, Kardanakhishvili ZB, Strugailo EV. The creation and maintenance of vascular access for chronic hemodialysis in the Moscow region: a five-year experience of a regional center.Russian Journal of Transplantology and Artificial Organs. 2018;20(4):44-53. doi: 10.15825/1995-1191-2018-4-44-53 (In Russ.)
  6. Schwab SJ, Quarles LD, Middleton JP, Cohan RH, Saeed M, Dennis VW. Hemodialysis-associated subclavian vein stenosis. Kidney Int. 1988 Jun;33(6):1156-59. doi: 10.1038/ki.1988.124
  7. Kouvelos GN, Spanos K, Antoniou GA, Vassilopoulos I, Karathanos C, Matsagkas MI, Giannoukas AD. Balloon angioplasty versus stenting for the treatment of failing arteriovenous grafts: a meta-analysis. Eur J Vasc Endovasc Surg. 2018 Feb;55(2):249-256. doi: 10.1016/j.ejvs.2017.11.011
  8. Schmidli J, Widmer MK, Basile C, de Donato G, Gallieni M, Gibbons CP, Haage P, Hamilton G, Hedin U, Kamper L, Lazarides MK, Lindsey B, Mestres G, Pegoraro M, Roy J, Setacci C, Shemesh D, Tordoir JHM, van Loon M, Esvs Guidelines Committee, Kolh P, de Borst GJ, Chakfe N, Debus S, Hinchliffe R, Kakkos S, Koncar I, Lindholt J, Naylor R, Vega de Ceniga M, Vermassen F, Verzini F, Esvs Guidelines Reviewers, Mohaupt M, Ricco JB, Roca-Tey R. Editors Choice Vascular Access: 2018 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018 Jun;55(6):757-18. doi: 10.1016/j.ejvs.2018.02.001
  9. Agarwal AK. Central vein stenosis. Am J Kidney Dis. 2013 Jun;61(6):1001-15. doi: 10.1053/j.ajkd.2012.10.024
  10. Stern AB, Klemmer PJ. High-output heart failure secondary to arteriovenous fistula. Hemodial Int. 2011 Jan;15(1):104-7. doi: 10.1111/j.1542-4758.2010.00518.x
  11. Browne LD, Bashar K, Griffin P, Kavanagh EG, Walsh SR, Walsh MT. The Role of Shear Stress in Arteriovenous Fistula Maturation and Failure: A Systematic Review. PLoS One. 2015 Dec 30;10(12):e0145795. doi: 10.1371/journal.pone.0145795. eCollection 2015.
  12. Oguzkurt L, Tercan F, Yildirim S, Torun D. Central venous stenosis in haemodialysis patients without a previous history of catheter placement. Eur J Radiol. 2005 Aug;55(2):237-42. doi: 10.1016/j.ejrad.2004.11.006
  13. Haskal ZJ, Saad TF, Hoggard JG, Cooper RI, Lipkowitz GS, Gerges A, Ross JR, Pflederer TA, Mietling SW. Prospective, randomized, concurrently-controlled study of a stent graft versus balloon angioplasty for treatment of arteriovenous access graft stenosis: 2-year results of the RENOVA study. J Vasc Interv Radiol. 2016 Aug;27(8):1105-14.e3. doi: 10.1016/j.jvir.2016.05.019
  14. Khawaja AZ, Cassidy DB, Al Shakarchi J, McGrogan DG, Inston NG, Jones RG. Systematic review of drug eluting balloon angioplasty for arteriovenous haemodialysis access stenosis. J Vasc Access. 2016 Mar-Apr;17(2):103-10. doi: 10.5301/jva.5000508
  15. Hongsakul K, Bannangkoon K, Rookkapan S, Boonsrirat U, Kritpracha B. Paclitaxel-coated balloon angioplasty for early restenosis of central veins in hemodialysis patients: a single center initial experience. Korean J Radiol. 2018 May-Jun;19(3):410-16. doi: 10.3348/kjr.2018.19.3.410
Address for correspondence:
129110, Russian Federation,
Moscow, Shchepkin str, 61/2, 6,
tel.: +7-916-705-98-99,
Zulkarnaev Alexey B.
Information about the authors:
Kardanakhishvili Zurab B., Post-Graduate Student of the Department of Transplantation, Nephrology and Artificial Organs of the Faculty of Advanced Training, Moscow Regional Research and Clinical Institute named after M.F.Vladimirsky, Surgeon of the Department of Vascular Surgery, M. E. Zhadkevich Moscow City Clinical Hospital, Moscow, Russian Federation.
Zulkarnaev Alexey B., Leading Researcher, the Surgical Department of Kidney Transplantation, Moscow Regional Research and Clinical Institute Named after M.F.Vladimirsky, Moscow, Russian Federation.
Rogozin Vasily V., Surgeon of the Department of Vascular Surgery, Moscow Hospital No2 for War Veterans of the Department of Health Care of Moscow, Moscow, Russian Federation.
Stepanov Vadim A., Senior Researcher of the Surgical Department of Kidney Transplantation, Moscow Regional Research and Clinical Institute named after M.F.Vladimirsky, Moscow, Russian Federation.



Saratov State Medical University Named after V.I. Razumovsky, Saratov,
The Russian Federation

Objective. Analysis of the causes, nature of complaints against surgeons, studying of problems of protecting the professional activities of a physician.
Methods. According to information provided by the Territorial Authority to monitor the health service quality in Saratov Region, for the period of 2018 5 months of 2019, 1699 citizens complaints were received. 42 complaints were received regarding the quality of medical care in the medical institutions of the region in the surgery profile, which accounted for 9.3% of the total number of complaints.
Results. According to the information received, the most claims against surgeons was registered in Central Regional Hospitals (CRH) 10 (23.8%) complaints. The first place in terms of the number of complaints is taken by surgical departments of hospitals 16 (38.1%) cases, the second place outpatient clinics of the Central Regional Hospital and polyclinics [14 (33.3%) cases], the third place private clinics [7 (16.7 %) cases].
The essence of many complaints, first of all, consists in appealing for professional analysis of treatment case with an unfavorable outcome. In case of unsuccessful treatment, the majority of patients and their relatives most often [24 (57.1%) cases] demanded simply an examination of the treatment case and / or medical institution, and not criminal punishment. In 1 (2.4%) case, the patient simply wanted to report a problem related to the diagnosis and treatment of his disease. There was no information about any criminal punishment of the surgeons in the text of their complaints.
Conclusion. The surgeon-patient conflict in the form of a complaint is a structurally complex process with objective and subjective components that are influenced by a wide variety of risk factors. The growing discrepancy between the protection of a patient and a surgeon during the transfer of complaints to supervisory and legal authorities gradually increases the distortion of their analysis.

Keywords: surgery, medical error, conflict, law, complaint
p. 527-535 of the original issue
  1. Doskin VA, Derinova EA, Kartoeva RA, Sokolova MS. Medical errors and conflicts in clinical practice. Klin Meditsina. 2014;92(4):57-63. (In Russ.)
  2. Bagmct AM. Without the complications of medicine does not happen? Aktualnye Problemy Meditsiny & Biologii. 2018;(2):6-10. doi: 10.24411/2587-4926-2018-10002 (In Russ.)
  3. Konanykhina AK, Komarova GA, Kochubei AV. Pravo na oshibku: vrachebnye oshibki glazami vrachei i patsientov. Klin Praktika. 2018;9(3):70-72. 2018;9(3):70-72. (In Russ.)
  4. Konstitutsiia Rossiiskoi Federatsii [Elektronnyi resurs]. 1993 [data obrashcheniia: 2019 Okt 20]. Rezhim dostupa: ( In Russ.)
  5. O poriadke rassmotreniia obrashchenii grazhdan Rossiiskoi Federatsii: Federalnyi zakon; 59 FZ [Elektronnyi resurs]. 2006 May 2 [data obrashcheniia: 2019 Okt 20]. Rezhim dostupa: ( In Russ.)
  6. Ugolovnyi kodeks Rossiiskoi Federatsii; 63-FZ (red. ot 02.08.2019) [Elektronnyi resurs]. 1996 Iiun 13 [data obrashcheniia: 2019 Okt 20]. Rezhim dostupa:
  7. Davydovskii IV. Vrachebnye oshibki. Sovet Meditsina. 1941;(3):3-10. ( In Russ.)
  8. Lesnichenko AM. Vrachebnaia oshibka. Vopr Nauki i Obrazovaniia [Elektronnyi resurs]. 2018;(13):66-78. Rezhim dostupa: ( In Russ.)
  9. Isakov VD. Professionalnye pravonarusheniia meditsinskikh rabotnikov i ikh sudebno-meditsinskaia ekspertiza: lektsii. S-Peterburg, RF; 2004.
  10. World Medical Association Declaration of Geneva [Internet] [cited 2019 Oct 20]. Available from:
  11. Ob osnovakh okhrany zdorovia grazhdan v Rossiiskoi Federatsii: Federalnyi zakon; 323-FZ [Elektronnyi resurs]. 2011 November 21 [data obrashcheniia: 2019 Okt 20]. Rezhim dostupa:
  12. Shevtsova YuV, Emelina AV, Zaharova EA. To the issue about the conflicts between doctors and patients and psychological preparation of doctors for work. Med Alm. 2011;(5):36-39. ( In Russ.)
  13. Bobrov OE. Vrachebnaia oshibka ili professionalnoe nevezhestvo? Mify, illiuzii, realnost [Elektronnyi resurs]. TRIGGER. 2016 Mart 13 [data obrashcheniia: 2019 Okt 20]. Rezhim dostupa: (In Russ.)
Address for correspondence:
410012, Russian Federation,
Saratov, Bolshaya Kazachya str., 112,
Saratov State Medical University Named
after V.I. Razumovsky of the Ministry of Health,
the Department of Surgery and Oncology
tel. mobile: +7 937 969-59-53,
Podelyakin Konstantin A.
Information about the authors:
Fedorov Vladimir E., MD, Professor of the Department of Surgery and Oncology, Saratov State Medical University Named after V.I. Razumovsky, Saratov, Russian Federation.
Podelyakin Konstantin A., Resident of the Department of Surgery and Oncology, Saratov State Medical University Named after V.I. Razumovsky, Saratov, Russian Federation.



Chita State Medical Academy, Chita,
The Russian Federation

Objective. To determine the peripheral neurofilament H level in patients and to evaluate the changes of bioelectrical muscle potentials of the affected persons in different periods of cryodamage.
Methods. The study included 30 patients. The victims were hospitalized to the regional thermal trauma center on the basis of the city hospital No1 in Chita with local cold injury of the distal segments of the feet in the period from 2018 to 2019. On the 5th and 30th days from the moment of injury the measurement of bioelectric activity was performed. The method of cutaneous electroneuromyography was used to assess the bioelectrical muscle activity. On the 5th and 30th days after cryotrauma the concentration of peripheral neurofilament H in the blood serum was determined by the IEA method using Vector-best reagents.
Results. On the 5th day from the moment of cryotrauma in the study group, the level of peripheral neurofilament was higher relative to the control indicators The amplitude of the M-response, the residual latency and the rate of propagation of excitation were significantly lower relative to the control. On the 30th day compared to the earlier period there was a reduction of the peripheral neurofilament level but the value remains higher than the control ones. At the same time, the studied electroneuromyography indicators elevated in comparison with the data in the early stages of cryotrauma, but they were still lower than the control group. An increase in neuromuscular activity was revealed in the victims relative to an earlier period of cryoinjury, which indicates the restoration of nerve conduction.
Conclusion. In patients with frostbite of II-IV degree, a sharp elevation in phosphorylated peripheral neurofilament was detected in the blood within different periods of cryodamage. At different times of local cold injury (II-IV degree) a reduction in the bioelectric activity of the muscles was observed. On the 30th day of complex treatment, relatively earlier period, the elevation of the bioelectrical muscle activity and a reduction of the level of neurophilament H were noted.

Keywords: local cold injury, peripheral neurodestruction, endothelial dysfunction, phosphorylated neurofilament N, violation of microcirculation
p. 536-542 of the original issue
  1. Mikhailichenko M.I., Shapovalov K.G. Microcirculatory disturbances in the pathogenesis of local cold injuries. Regional blood circulation and microcirculation. 2019;18(2):4-11. doi: 10.24884/1682-6655-2019-18-2-4-11 (In Russ.)
  2. Vinnik JuS, Jureva MJu, Tepljakova OV, Salmina AB, Tretjakova NG. Znachenie jendotelialnoj disfunkcii v patogeneze lokalnoj holodovoj travmy. RMZh. Med Obozrenie. 2014;22(31):2204-06. a/Znachenie_endotelialynoy _disfunkcii_v_patogeneze_lokalynoy_holodovoy_travmy/ (In Russ.)
  3. Shapkin JuG, Stekolnikov NJu, Gamzatova PK, Odnokozova JuS. Jendotelialnaja disfunkcija v otdaljonnom periode holodovoj travmy. Vestn Jeksperim i Klin Hirurgii. 2014;(4):359-63. (In Russ.)
  4. Metabolism in the hand tissues and functional microcirculation recourses in patients with sequelae of cold injury treated with the Ilizarov method. Genij Ortopedii. 2017;23(4):460-66. doi: 10.18019/1028-4427-2017-23-4-460-466 (In Russ.)
  5. Remnev AG, Olejnikov AA. Jelektronejromiografija: analiziruemye parametry. Mezhdunar Zhurn Priklad i Fundam Issledovanij. 2013;(10 ch 2): 281-82. In Russ.)
  6. Ruiatkina LA, Ruiatkin DS. Pancreatogenic diabetes / type 3c diabetes: status update on the problem. Med Sovet. 2018;(4):28-35. doi: 10.21518/2079-701X-2018-4-28-35 (In Russ.)
  7. Malonina EA, Kulibin AYU. Modelling of co-cultivation of sertoli-like cells in mice with spermatogonial cells. Kletochnye Tehnologii v Biologii i Medicine. 2019;(2):133-38. In Russ.)
  8. Porseva VV, Smirnova VP, Korzina MB, Emanuilov AI, Masliukov PM. Age-associated changes in sympathetic neurons containing neurofilament 200 during chemical deafferentation. . 2013;155(2):237-240. (In Russ.)
  9. Alekseev AA, Alekseev RZ, Bregadze AA, Konnov VA, Mihajlichenko AV, Semenova SV, Sizonenko VA, Skvorcov JuR, Shapovalov KG. Diagnostika i lechenie otmorozhenij (klinicheskie rekomendacii) [Jelektronnyj resurs]. Rezhim dostupa: (In Russ.)
  10. Vasina LV, Vlasov TD, Petrishchev NN. Functional heterogeneity of the endothelium (the review). Arterial Hypertension. 2017;23(2):88-102. doi: 10.18705/1607-419X-2017-23-2-88-102 (In Russ.)
  11. Yanagisawa H. Hypothermia, chilblain and frostbite. Nihon Rinsho. 2013 Jun;71(6):1074-78. [Article in Japanese]
  12. Li H, Jia J, Min Xu, Zhang L. Changes in the blood-nerve barrier after sciatic nerve cold injury: indications supporting early treatment. Neural Regen Res. 2015 Mar; 10(3):419-24. doi: 10.4103/1673-5374.153690
  13. Kovrazhkina EA, Stahovskaya LV, Razinskaya OD. Axonal degeneration and secondary demyelization in the central and peripheral nervous system. Consilium Medicum. 2016;18(9):87-91. (In Russ.)
  14. Li H, Zhang L, Xu M. Dexamethasone prevents vascular damage in early-stage non-freezing cold injury of the sciatic nerve. Neural Regen Res. 2016 Jan;11(1):163-67. Doi: 10.4103/1673-5374.175064
Address for correspondence:
672000, Russian Federation,
Chita, Gorkii str., 39 .
Chita State Medical Academy,
the Department of Faculty Surgery
with the Course of Urology,
tel.: 8 9145 22 29 22,
Mikhailichenko Maxim I.
Information about the authors:
Mikhailichenko Maxim I., PhD, Assistant of the Department of Faculty Surgery with the Course of Urology, Chita State Medical Academy, Chita, Russian Federation.
Shapovalov Konstantin G., MD, Professor, Head of the Department of Anesthesiology, Resuscitation and Intensive Care, Chita State Medical Academy, Chita, Russian Federation.
Mudrov Victor A., PhD, Associate Professor of the Department of Obstetrics and Gynecology, the Medical Faculty, the Dental Faculty, Chita State Medical Academy, Chita, Russian Federation.
Figurski Sergei A., Clinical Resident of the Department of Faculty Surgery with the Course of Urology, Chita State Medical Academy, Chita, Russian Federation.
Mikhailichenko Sergei I., PhD, Cardiac Surgeon, the Main Out-Of-Staff Hospital Named after N.N. Burdenko, Moscow, Russian Federation



A.N.Ryzhikh National Medical Research Center of Coloproctology of the Ministry of Health of Russia 1, Moscow,
N.F.Gamaleya Federal Research Center of Epidemiology and Microbiology 2, Moscow,
The Russian Federation

Objective. To study the effect of low-temperature argon plasma in the wound treatment after open hemorrhoidectomy.
Methods. The patients (n=30) with combined grade IV hemorrhoids were included in the study and ran-domized into the main and control groups. The age and gender in both groups were homogeneous.
Patients underwent the open hemorrhoidectomy using monopolar electrocoagulation during the postoperative period. Cold atmospheric plasma (CAP) was used as an addition physiotherapy in the main group. Cytological and bacteriological examination taken from the surface of the wound was carried out on days 2nd, 4th, 6th, 8th, 14th, 21st, 30th. Visual analogue scale (VAS, 0 to 10 points) was used to determine pain syndrome. Quality of life was assessed before surgery, on the 8th and 30th days since using the SF-36 questionnaire.
Results. By the 30th day, wound healing in the main group had occurred in 12/15 (80%) patients versus only 3/15 (20%) in the control group (p=0.003). On the 8th day after surgery the first signs of wound repair were determined in the main group, while only the signs of inflammation were detected in the control group according to the cytological study. On the 21st day the epithelial cells appeared in the main group versus wound repair process in the control group. On the 21st day the number of gram-negative bacteria was 105 versus 107 CFU, p<0.05, respectively) and the number of gram-positive bacteria was 107 CFU versus 108, (p>0.05) in the main and control groups, respectively. One established a t rialable difference in the microbial load of gram-negative bacteria in the CAP and control groups (105 versus 107 CFU, p<0.05, respectively). Microbial load of gram-positive bacteria in the CAP group was 107 CFU versus 108 in the control group (p>0.05). On the 6th day after surgery VAS score was 4 and 6 points, respectively (=0,01) in the main and control groups. Quality of life was measured on the 8th and 30th days after surgery. The reliable difference was found in the physical component assessment (p<0.05). There were no relevant differences in levels of psychological component between groups (p>0.05).
Conclusion. CAP application leads to accelerated wound healing and reduction of pain syndrome which has been observed.

Keywords: hemorrhoids, hemorrhoidectomy, cold argon plasma, plasma scalpel, plasma flow, wound healing
p. 543-550 of the original issue
  1. Shelygin JuA, Blagodarnyj LA, red. Spravochnik po koloproktologii. Moscow, RF: Littera; 2012. 596 p. (In Russ.)
  2. Chuangsuwanich A, Assadamongkol T, Boonyawan D. The Healing effect of low-temperature atmospheric-pressure plasma in pressure ulcer: a randomized controlled trial. Int J Low Extrem Wounds. 2016 Dec;15(4):313-19. doi: 10.1177/1534734616665046
  3. Shulutko AM, Kachikin AS, Yasnogorodsky OO, Aldykin MV, Gandybina EG, Semikov VI, Vinarskaya VA. The use of the plasmajet system in chest surgery. Moskov Hirurg Zhurn. 2011;(5):34-38. (In Russ.)
  4. Vorobev GI, Shelygin JuA, Blagodarnyj LA. Gemorroj: ruk. Moscow, RF: Littera; 2010. 200 p. (In Russ.)
  5. Kuzin MI. Rany i ranevaja infekcija: ruk dlja vrachej. Moscow: Medicina; 1990: 592 p. (In Russ.)
  6. Friedman G, Gutsol A, Shekhter AV, Vasilets VN, Fridman A. Applied plasma medicine. Plasma Process Polymers. 2008;5(6):503-33. doi: 10.1002/ppap.20070015
  7. Traba C, Liang JF. The inactivation of Staphylococcus aureus biofilms using low-power argon plasma in a layer-by-layer approach. Biofouling. 2015;31(1):39-48. doi: 10.1080/08927014.2014.995643
  8. Joshi SG, Cooper M, Yost A, Paff M, Ercan UK, Fridman G, Friedman G, Fridman A, Brooks AD. Nonthermal dielectric-barrier discharge plasma-induced inactivation involves oxidative DNA damage and membrane lipid peroxidation in Escherichia coli. Antimicrob Agents Chemother. 2011 Mar;55(3):1053-62. doi: 10.1128/AAC.01002-10
  9. Mai-Prochnow A, Clauson M, Hong J, Murphy AB. Gram positive and Gram negative bacteria differ in their sensitivity to cold plasma. Scientific Reports. 2016 Dec;6:38610. doi: 10.1038/srep3861
  10. Wende K, Bekeschus S, Schmidt A, Jatsch L, Hasse S, Weltmann KD, Masur K, von Woedtke T. Risk assessment of a cold argon plasma jet in respect to its mutagenicity. Mutat Res Genet Toxicol Environ Mutagen. 2016 Mar;798-99:48-54. doi: 10.1016/j.mrgentox.2016.02.003
  11. Moisan M, Barbeau J, Moreau S, Pelletier J, Tabrizian M, Yahia LH. Low-temperature sterilization using gas plasmas: a review of the experiments and an analysis of the inactivation mechanisms. Int J Pharm. 2001 Sep 11;226(1-2):1-21. doi: 10.1016/s0378-5173(01)00752-9
Address for correspondence:
123154,Russian Federation,
Moscow, Salyam Adil str., 2,
A.N. Ryzhikh National Medical
Research Center of Coloproctology
of the Ministry of Health of Russia,
Department of General Coloproctology
with a Group Studying Familial the Colon Adenomatosis,
tel.: 8 926 188-31-29,
Tuktagulov Nikita V.
Information about the authors:
Kuzminov Alexander M., MD, Professor, Head of the Department of General Coloproctology with a Group Studying Familial Colon Adenomatosis, A.N. Ryzhikh National Medical Research Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russian Federation.
Frolov Sergey A., MD, Deputy Director, A.N. Ryzhikh National Medical Research Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russian Federation.
Vyshegorodtsev Dmitry V., PhD, Senior Researcher of the Department of General Coloproctology with a Group Studying Familial Colon Adenomatosis, A.N. Ryzhikh National Medical Research Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russian Federation.
Korolik Vyacheslav Yu., PhD, Researcher of the Department of General Coloproctology with a Group Studying Familial Colon Adenomatosis, A.N. Ryzhikh National Medical Research Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russian Federation.
Tuktagulov Nikita V., Post-Graduate Student of the Coloproctology Department, A.N. Ryzhikh National Medical Research Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russian Federation.
Sukhina Marina A., PhD, Head of the Department of Studying Microbiological and Immunological Researches, A.N. Ryzhikh National Medical Research Center of Coloproctology of the Ministry of Health of Russia, Moscow, Russian Federation.
Vorojebva Irina V., PhD, Senior Researcher, N.F.Gamaleya Federal Research Center of Epidemiology and Microbiology, Moscow, Russian Federation.




Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk,
The Russian Federation

Objective. To identify features of the endothelial dysfunction in the development of postoperative hemorrhagic complications in patients with urolytiasis.
Methods. A study of patients (n=174) with urolithiasis was conducted. Patients were divided into two clinical groups: group I 93 patients, with an uncomplicated postoperative course; group II 81 patients with the developed hemorrhagic complications. In the preoperative period and 3 days after the operation, the expression of CD38 and CD31 on lymphocytes was evaluated; counting the number of membranes of released microparticles, and also estimating blebbing of peripheral blood lymphocytes.
Results. In the preoperative period, an increase in expression of CD 38 and CD 31 lymphocytes was recorded, it was more pronounced in the II clinical group. In patients of clinical group I, the number of lymphocytes in the initial and terminal blebbing state was within the mean values of the control group. In clinical group II, there was a significant increase in these indicators. The number of free lymphocyte-derived microparticles in the peripheral blood of patients was statistically increased in clinical group II and was 874 [643; 1095]. Analyzing the data obtained in the postoperative period, a statistically significant increase in expression of CD 38 and CD 31 lymphocytes prevailing in the II clinical group was revealed, the number of lymphocytes with an initial blebbing state was increased (7.61 and 9.26, respectively). The end-state blebbing lymphocyte score was increased in both clinical groups (8.55 and 19.17, respectively).
Conclusion. Thus, the endothelial insufficiency develops inpatients uitiurolithiasis in the postoperative period patients with urolithiasis. However, in the development of hemorrhagic complications, the mechanism and expression of intercellular communication in the pathogenesis of endothelium dysfunction formation is considered to be significantly different, which should be taken into account in the course of operative treatment and administration of hemostatic therapy in the early postoperative period.

Keywords: urolytiasis, hemorrhagic complications, endothelial dysfunction, blebbing, membranes released microparticles
p. 551-557 of the original issue
  1. Dutov VV. Distancionnaja udarno-volnovaja litotripsija: nazad v budushhee. RMZh. 2014;(29):2077-86. (In Russ.)
  2. Trapeznikova MF, Dutov VV, Rumjancev AA, Tumanjan VG. Distancionnaja udarno-volnovaja litotripsija v lechenii urolitiaza distopirovannyh pochek. Sarat Nauch-Med Zhurn. 2011;7(S2):245-48. (In Russ.)
  3. Zhebentjaev AA. Konservativnoe lechenie i distancionnaja litotripsija pri lechenii mochekamennoj bolezni. Vestn VGMU. 2007;6(3):5-12. (In Russ.)
  4. Hasigov AV, Hazhokov MA, Belousov II, Kogan MI. Ural Med Zhurn. 2013;(4):95-100. Shock-wave lithotripsy or percutaneous nephrolithotomy in large and staghorn stones: technical features and complications. Ural Med Zhurn. 2013;(4):95-100. (In Russ.)
  5. Malhasjan VA, Semenjakin IV, Ivanov VJu, Suhih SO, Gadzhiev NK. Complications of percutaneous nephrolithotomy and their management. Urologija. 2018;(4):147-53. doi: 10.18565/urology.2018.4.147-153 (In Russ.)
  6. Zhuravlev VN, Danilov VO, Bazhenov IV, Beresteckij IE, Borzunov IV, Vahlov SG, Makarjan AA. Percutaneous nephrolithotripsy: the algorithm of actions in identifying bleeding from renal vessels. Ural Med Zhurn. 2016;(1):10-13. (In Russ.)
  7. Rossolovsky A.N., Chekhonatskaya M.L., Zakharova N.B., Berezinets O.L., Emelyanova N.V. Dynamic evaluation condition of renal parenchyma in patients after external shock wave lithotripsy of kidney stones. Urology Herald. 2014;(2):3-14. doi: 10.21886/2308-6424-2014-0-2-3-14 (In Russ.)
  8. Inzhutova AI, Larionov AA, Salmina AB, Petrova MM. Molecular and cellular mechanisms of endothelial dysfunction in different pathology. report 1. Sib Med Zurn (Irkutsk). 2010;96(5):85-88. (In Russ.)
  9. Kondrateva TS, BabincevA AU. Estimation of blebbing-phenomena as a method of diagnostic degree of diabetic polyneuropathy. Vestn Soveta Molodyh Uchenyh i Specialistov Cheljab Oblasti. 2018;3(22):98-102. (In Russ.)
  10. Tixeira R, Phan TK, Caruso S, Shi B, Atkin-Smith GK, Nedeva C, Chow JDY, Puthalakath H, Hulett MD, Herold MJ, Poon IKH. ROCK1 but not LIMK1 or PAK2 is a key regulator of apoptotic membrane blebbing and cell disassembly. Cell Death Differ. 2020;27(1):102-16. doi: 10.1038/s41418-019-0342-5
  11. Obeidy P, Ju LA, Oehlers SH, Zulkhernain NS, Lee Q, Galeano Niño JL, Kwan RY, Tikoo S, Cavanagh LL, Mrass P, Cook AJ, Jackson SP, Biro M, Roediger B, Sixt M, Weninger W. Partial loss of actin nucleator actin-related protein 2/3 activity triggers blebbing in primary T lymphocytes. Immunol Cell Biol. 2020 Feb;98(2):93-13. doi: 10.1111/imcb.12304
  12. Moroz VV, Salmina AB, Fursov AA, Mihutkina SV, Linev KA, Mantorova NS, Shahmaeva SV, Olhovskij IV, Isakov IV. Rol membrannyh vysvobozhdennyh mikrochastic v patogeneze sistemnogo vospalitelnogo otveta. Vestn Ros Akad med nauk. 2010;(4):3-8. (In Russ.)
  13. Vinnik YuS, Dunaevskaya SS, Antufrieva DA. Deulina VV, Microparticles of lymphocytic origin a pathogenetic marker of necrotizing pancreatitis.. Jeksperim i Klin Gastrojenterologija. 2019;(5):84-90. doi: 10.31146/1682-8658-ecg-165-5-84-90 (In Russ.)
  14. Mobarrez F, Fuzzi E, Gunnarsson I, Larsson A, Eketjäll S, Pisetsky DS, Svenungsson E. Microparticles in the blood of patients with SLE: Size, content of mitochondria and role in circulating immune complexes. J Autoimmun. 2019 Aug;102:142-49. doi: 10.1016/j.jaut.2019.05.003
Address for correspondence:
660077, Russian Federation,
Krasnoyarsk, Partizan Zheleznyak str., 1,
Voino-Yasenetsky Krasnoyarsk
State Medical University,
the General Surgery Department
Named after pr. M.I. Gulman,
tel. office:+963-191-29-70,
Dunaevskaya Svetlana S.
Information about the authors:
Dunaevskaya Svetlana S., MD, Professor, the General Surgery Department Named after pr. M.I. Gulman, Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russian Federation.
Vinnik Yurii S., MD, Professor, Head of the General Surgery Department Named after pr.M.I.Gulman, Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russian Federation.
Berezhnoi Alexandr G., PhD, Associate Professor of the Department of Urology, Andrology and Sexology, Institute of Post-Educational Training, Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russian Federation.




Mogilev Regional Clinical Hospital 1,
Mogilev Hospital No1 2, Mogilev,
Vitebsk State Medical University 3, Vitebsk ,
The Republic of Belarus

Objectives. To determine changes in platelet aggregation during intensive care of critically ill patients with COVID-19 infection.
Methods. A pilot non-randomized prospective clinical study of platelet aggregation in patients admitted to the intensive care unit with acute respiratory distress syndrome with the diagnosis of COVID-19 (group 1, n=15) was carried out. A control group (group 2, n=15) included healthy people who have ambulatory study of platelet aggregation. In the 1st-3d days of hospitalization at the intensive care blood sampling was carried out in the group 1. The study was performed on a platelet aggregation analyzer AR 2110 (ZAO SOLAR, Republic of Belarus).
Results. When platelet aggregation was induced by high doses of ADP (1.25 and 2.5 μg/ml), a lower degree of aggregation was observed in patients with COVID-19 (58.7 (34.2; 63.2)% and 66.5 (59.6; 70.9)% vs 67.2 (64.1; 70.3)% and 77.5 (71.8; 80.3)% in group 2, respectively, (p<0.05)), which occurred significantly faster (161.5 (103; 214) s and 197 (127; 309) s compared to 413 (325; 465) s and 362.5 (296.5; 422) s in group 2, respectively, (p<0.05)). With the inducer adrenaline at doses of 2.5 and 5 μM the degree of aggregation was also significantly lower in patients with COVID-19 (40.8 (26.1; 63.9)% and 38.7 (29.4; 66.8 )%, respectively). Single-phase irreversible platelet aggregation with an aggregation degree of 75.2 (71.9; 83.2) % was observed with a collagen inducer in patients with COVID-19 infection.
Conclusion. The degree of platelet aggregation with ADP and adrenaline was significantly reduced in patients with COVID-19 infection due to receiving anticoagulant and antiplatelet therapy (by main and concomitant pathologies).

Keywords: platelet aggregation, Covid-19, SARS-CoV-2, platelets, platelet aggregation, hypercoagulation, coagulation balance
p. 558-564 of the original issue
  1. Solovei NV, Karpov IA, Gorbich IuL. COVID-19 infektsiia: sovremennye vozmozhnosti i perspektivy protivovirusnogo lecheniia. Retsept. Spetsvyp: COVID-19: chto dolzhen znat kazhdyi vrach. 2020;23(2):163-71. (In Russ.)
  2. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19). Treatment Guidelines [Electronic resource]. National Institutes of Health; 2020 [ : 2020 23]. Available from:
  3. Escher R, Breakey N, Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020 Jun;190:62. doi: 10.1016/j.thromres.2020.04.014
  4. Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, Pesenti A, Peyvandi F, Tripodi A. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020 Jul;18(7):1738-42. doi: 10.1111/jth.14850
  5. Carsana L, Sonzogni A, Nasr A, Rossi RS, Pellegrinelli A, Zerbi P, Rech R, Colombo R, Antinori S, Corbellino M, Galli M, Catena E, Tosoni A, Gianatti A, Nebuloni M. Pulmonary post-mortem findings in a large series of COVID-19 cases from northern Italy [Internet]. Published online 2020 Apr 22. doi: 10.1101/2020.04.19.20054262
  6. Schaller T, Hirschbühl K, Burkhardt K, Braun G, Trepel M, Märkl B, Claus R. Postmortem examination of patients with COVID-19. JAMA. 2020 Jun 23;323(24):2518-20. doi: 10.1001/jama.2020.8907
  7. Koupenova M. Potential role of platelets in COVID-19: Implications for thrombosis. Res Pract Thromb Haemost. 2020 Jul;4(5):737-40. Published online 2020 Jun 21. doi: 10.1002/rth2.12397
  8. Yang X, Yang Q, Wang Y, Wu Y, Xu J, Yu Y, Shang Y. Thrombocytopenia and its association with mortality in patients with COVID-19. J Thromb Haemost. 2020 Jun;18(6):1469-72. doi: 10.1111/jth.14848
  9. Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. The unique characteristics of COVID-19 coagulopathy. Crit Care. 2020 Jun 18;24(1):360. doi: 10.1186/s13054-020-03077-0
  10. Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost. 2020;18:2103-09. doi: 10.1111/jth.14975
  11. Zubovskaia ET, Iurkevich TIu, Mitroshenko IV, Demidova RN. Trombotsitarnaia agregatometriia v klinicheskoi praktike: posobie dlia vrachei. Minsk, RB: ProniaPlius; 2018. 67 p.(In Russ.)
  12. Marini JJ, Gattinoni L. Management of COVID-19 respiratory distress. JAMA. 2020;323(22):2329-30. doi: 10.1001/jama.2020.6825
Address for correspondence:
212016, Republic of Belarus,
Mogilev, Belynickij-Biruli str., 12,
Mogilev Regional Clinical Hospital,
the Department for Coordinating
the Collection of Organs and Tissues
for Transplantation,
tel.: +375 222 62-75-95,,
Lipnitski Artur Leonidovich
Information about the authors:
Marochkov Alexey V., MD, Professor, Anesthesiologist-Resuscitator, the Intensive Care Unit, Mogilev Regional Clinical Hospital, the Affiliate of the Department of Anesthesiology and Reanimatology with the Course of the Faculty of Advanced Training and Retraining of Specialists and the Surgery Department of the Faculty of Advanced Training and Retraining of Specialists, Vitebsk State Medical University, Mogilev, Republic of Belarus.
Lipnitski Artur L., PhD, Anesthesiologist-Resuscitator, Head of the Department for Coordinating the Collection of Organs and Tissues intended for Transplantation, Mogilev Regional Clinical Hospital, the Affiliate of the Department of Anesthesiology and Reanimatology, with the Course of the Faculty of Advanced Training and Retraining of Specialists and the Surgery Department of the Faculty of Advanced Training and Retraining of Specialists, Vitebsk State Medical University, Mogilev, Republic of Belarus.
Tsopau Dmitry S., Anesthesiologist-Resuscitator, the Intensive Care Unit, Mogilev Hospital No1, Mogilev, Republic of Belarus.;
Kupreyeva Irina A., Head of the Centralized Laboratory of Clinical Biochemistry, Mogilev Regional Clinical Hospital, Mogilev, Republic of Belarus.
Dazortsava Olga V., Physician of Laboratory Diagnostics of the Centralized Laboratory of Clinical Biochemistry, Mogilev Regional Clinical Hospital, Mogilev, Republic of Belarus.




Kharkov National Medical University of the Ministry of Health of Ukraine, Kharkov,

Many surgical treatment techniques of anal fistulas are not effective enough, since many of them negatively affect the quality of life of operated patients due to the development of partial or complete disorders including functional urinary and fecal incontinence and accompanied by a significant percentage of recurrent fistulas. Therefore usually requires a repeat operation. There are a number of publications and recommendations for the treatment of rectal fistulas, but many of them are controversial, making practical treatment decisions extremely difficult. Trying to achieve three main aims of treatment (closing the fistula, preserving the sphincter function and minimizing the healing time), various minimally invasive methods of preserving the sphincter have been proposed over the past decades: such as endorectal flap advancement, intrafistular injection of fibrin glue, or the insertion of hermetic swabs, injection of autologous stem cells in the fistulous tract, ligation of the intersphincteric fistula tract (LIFT), video-assisted anal fistula treatment and other techniques. Despite such a large arsenal of the proposed minimally invasive technologies in the treatment of anal fistulas, many unclear questions still remain concerning adapting the existing surgical options to more complex clinical cases.

Keywords: anal fistulas, minimally invasive methods of treatment, recommendations, advantages, disadvantages
p. 565-576 of the original issue
  1. Musin AI, Antipova EV, Ulyanov AA, Kuznetsov DE. Ligature method for the treatment of anal fistula: a modern view on the old approach (literature review). Grekovs Bulletin of Surgery. 2019;178(2):79-84. doi: 10.24884/0042-4625-2019-178-2-79-84 (In Russ.)
  2. Owen HA, Buchanan GN, Schizas A, Cohen R, Williams AB. Quality of life with anal fistula. Ann R Coll Surg Engl. 2016 May;98(5):334-38. doi: 10.1308/rcsann.2016.0136
  3. Abcarian H. Anorectal infection: abscess-fistula. Clin Colon Rectal Surg. 2011 Mar;24(1):14-21. doi: 10.1055/s-0031-1272819
  4. Alasari S, Kim NK. Overview of anal fistula and systematic review of ligation of the intersphincteric fistula tract (LIFT). Tech Coloproctol. 2014 Jan;18(1):13-22. doi: 10.1007/s10151-013-1050-7
  5. Lee MJ, Heywood N, Adegbola S, Tozer P, Sahnan K, Fearnhead NS, Brown SR. Systematic review of surgical interventions for Crohns anal fistula. BJS Open. 2017 Oct 17;1(3):55-66. doi: 10.1002/bjs5.13. eCollection 2017 Jun.
  6. Felt-Bersma RJ, Bartelsman JF. Haemorrhoids, rectal prolapse, anal fissure, peri-anal fistulae and sexually transmitted diseases. Best Pract Res Clin Gastroenterol. 2009;23(4):575-92. doi: 10.1016/j.bpg.2009.04.010
  7. Zanotti C, Martinez-Puente C, Pascual I, Pascual M, Herreros D, García-Olmo D. An assessment of the incidence of fistula-in-ano in four countries of the European Union. Int J Colorectal Dis. 2007 Dec;22(12):1459-62. doi: 10.1007/s00384-007-0334-7
  8. Hokkanen SR, Boxall N, Khalid JM, Bennett D, Patel H. Prevalence of anal fistula in the United Kingdom. World J Clin Cases. 2019 Jul 26;7(14):1795-804. Published online 2019 Jul 26. doi: 10.12998/wjcc.v7.i14.1795
  9. Jacob TJ, Perakath B, Keighley MR. Surgical intervention for anorectal fistula. Cochrane Database Syst Rev. 2010 May 12;(5):CD006319. doi: 10.1002/14651858.CD006319.pub2
  10. Bleier JIS, Moloo H. Current management of cryptoglandular fistula-in-ano. World J Gastroenterol. 2011 Jul 28;17(28):3286-91. Published online 2011 Jul 28. doi: 10.3748/wjg.v17.i28.3286
  11. Oh C. Management of high recurrent anal fistula. Surgery. 1983 Feb;93(2):330-32.
  12. Hjortrup A, Moesgaard F, Kjaergard J. Fibrin adhesive in the treatment of perineal fistulas. Dis Colon Rectum. 1991 Sep;34(9):752-54. doi: 10.1007/bf02051064
  13. Heydari A, Attinà GM, Merolla E, Piccoli M, Fazlalizadeh R, Melotti G. Bioabsorbable synthetic plug in the treatment of anal fistulas. Dis Colon Rectum. 2013 Jun;56(6):774-79. doi: 10.1097/DCR.0b013e3182839824
  14. Garcia-Olmo D, Garcia-Arranz M, Herreros D. Expanded adipose-derived stem cells for the treatment of complex perianal fistula including Crohns disease. Expert Opin Biol Ther. 2008 Sep;8(9):1417-23. doi: 10.1517/14712598.8.9.1417
  15. Rojanasakul A, Pattanaarun J, Sahakitrungruang C, Tantiphlachiva K. Total anal sphincter saving technique for fistula-in-ano; the ligation of intersphincteric fistula tract. J Med Assoc Thai. 2007 Mar;90(3):581-86.
  16. Meinero P, Mori L. Video-assisted anal fistula treatment (VAAFT): a novel sphincter-saving procedure for treating complex anal fistulas. Tech Coloproctol. 2011 Dec;15(4):417-22. doi: 10.1007/s10151-011-0769-2
  17. Wilhelm A. A new technique for sphincter-preserving anal fistula repair using a novel radial emitting laser probe. Tech Coloproctol. 2011 Dec;15(4):445-49. doi: 10.1007/s10151-011-0726-0
  18. Boyko V, Kryvoruchko I, Parhomenko K, Firsyc T, Bozhko O, Yevtushenko D. Surgical Treatment of Rectal Fistulae Using Biowelding. Int J Sci Educ (IJES). 2019;2(3):1-6. doi: 10.26697/ijes.2019.3.5
  19. Prosst RL, Ehni W. The OTSCⓇ Proctology clip system for anorectal fistula closure: the anal fistula claw: case report. Minim Invasive Ther Allied Technol. 2012 Jul;21(4):307-12. doi: 10.3109/13645706.2012.692690
  20. Limura E, Giordano P. Modern management of anal fistula. World J Gastroenterol. 2015 Jan 7;21(1):12-20. doi: 10.3748/wjg.v21.i1.12
  21. Ommer A, Herold A, Berg E, Fürst A, Post S, Ruppert R, Schiedeck T, Schwandner O, Strittmatter B. German S3 guidelines: anal abscess and fistula (second revised version). Langenbecks Arch Surg. 2017 Mar;402(2):191-201. doi: 10.1007/s00423-017-1563-z
  22. de Groof EJ, Cabral VN, Buskens CJ, Morton DG, Hahnloser D, Bemelman WA. Systematic review of evidence and consensus on perianal fistula: an analysis of national and international guidelines. Colorectal Dis. 2016 Apr;18(4):O119-34. doi: 10.1111/codi.13286
  23. Hilsabeck JR. Transanal advancement of the anterior rectal wall for vaginal fistulas involving the lower rectum. Dis Colon Rectum. 1980 May-Jun;23(4):236-41. doi: 10.1007/bf02587089
  24. Elting AW. X. The Treatment of fistula in ano: with especial reference to the whitehead operation. Ann Surg. 1912 Nov;56(5):744-52. doi: 10.1097/00000658-191211000-00010
  25. Göttgens KW, Vening W, van der Hagen SJ, van Gemert WG, Smeets RR, Stassen LP, Baeten CG, Breukink SO. Long-term results of mucosal advancement flap combined with platelet-rich plasma for high cryptoglandular perianal fistulas. Dis Colon Rectum. 2014 Feb;57(2):223-27. doi: 10.1097/DCR.0000000000000023
  26. van Onkelen RS, Gosselink MP, Thijsse S, Schouten WR. Predictors of outcome after transanal advancement flap repair for high transsphincteric fistulas. Dis Colon Rectum. 2014 Aug;57(8):1007-11. doi: 10.1097/DCR.0000000000000154
  27. Perez F, Arroyo A, Serrano P, Sánchez A, Candela F, Perez MT, Calpena R. Randomized clinical and manometric study of advancement flap versus fistulotomy with sphincter reconstruction in the management of complex fistula-in-ano. Am J Surg. 2006 Jul;192(1):34-40. doi: 10.1016/j.amjsurg.2006.01.028
  28. Sungurtekin U, Sungurtekin H, Kabay B, Tekin K, Aytekin F, Erdem E, Ozden A. Anocutaneous V-Y advancement flap for the treatment of complex perianal fistula. Dis Colon Rectum. 2004 Dec;47(12):2178-83. doi: 10.1007/s10350-004-0744-3
  29. van der Hagen SJ, Baeten CG, Soeters PB, van Gemert WG. Autologous platelet-derived growth factors (platelet-rich plasma) as an adjunct to mucosal advancement flap in high cryptoglandular perianal fistulae: a pilot study. Colorectal Dis. 2011 Feb;13(2):215-18. doi: 10.1111/j.1463-1318.2009.01991.x
  30. Bleier JI, Moloo H. Current management of cryptoglandular fistula-in-ano. World J Gastroenterol. 2011 Jul 28;17(28):3286-91. doi: 10.3748/wjg.v17.i28.3286
  31. Hjortrup A, Moesgaard F, Kjaergard J. Fibrin adhesive in the treatment of perineal fistulas. Dis Colon Rectum. 1991 Sep;34(9):752-54. doi: 10.1007/bf02051064
  32. Swinscoe MT, Ventakasubramaniam AK, Jayne DG. Fibrin glue for fistula-in-ano: the evidence reviewed. Tech Coloproctol. 2005 Jul;9(2):89-94. doi: 10.1007/s10151-005-0204-7
  33. Johnson EK, Gaw JU, Armstrong DN. Efficacy of anal fistula plug vs. fibrin glue in closure of anorectal fistulas. Dis Colon Rectum. 2006 Mar;49(3):371-76. doi: 10.1007/s10350-005-0288-1
  34. Amrani S, Zimmern A, OHara K, Corman ML. The Surgisis AFP anal fistula plug: a new and reasonable alternative for the treatment of anal fistula. Gastroenterol Clin Biol. 2008 Nov;32(11):946-48. doi: 10.1016/j.gcb.2008.09.003
  35. Ortiz H, Marzo J, Ciga MA, Oteiza F, Armendáriz P, de Miguel M. Randomized clinical trial of anal fistula plug versus endorectal advancement flap for the treatment of high cryptoglandular fistula in ano. Br J Surg. 2009 Jun;96(6):608-12. doi: 10.1002/bjs.6613
  36. The Surgisis AFP anal fistula plug: report of a consensus conference. Colorectal Dis. 2008 Jan;10(1):17-20. doi: 10.1111/j.1463-1318.2007.01423.x
  37. Buchberg B, Masoomi H, Choi J, Bergman H, Mills S, Stamos MJ. A tale of two (anal fistula) plugs: is there a difference in short-term outcomes? Am Surg. 2010 Oct;76(10):1150-53.
  38. Ratto C, Litta F, Donisi L, Parello A. Prospective evaluation of a new device for the treatment of anal fistulas. World J Gastroenterol. 2016 Aug 14;22(30):6936-43. doi: 10.3748/wjg.v22.i30.6936
  39. Cetinkaya E, Bulut B, Ersoz S, Guldogan CE, Akgul O, Yuksel BC, Aslar AK. Clinical Experience with Lift Technique For Complex Anal Fistulas. J Gastrointest Dig Syst. 2016;6:425. doi: 10.4172/2161-069X.1000425
  40. Ellis CN. Outcomes with the use of bioprosthetic grafts to reinforce the ligation of the intersphincteric fistula tract (BioLIFT procedure) for the management of complex anal fistulas. Dis Colon Rectum. 2010 Oct;53(10):1361-64. doi: 10.1007/DCR.0b013e3181ec4470
  41. Tan KK, Lee PJ. Early experience of reinforcing the ligation of the intersphincteric fistula tract procedure with a bioprosthetic graft (BioLIFT) for anal fistula. ANZ J Surg. 2014 Apr;84(4):280-83. doi: 10.1111/ans.12242
  42. Wilhelm A. A new technique for sphincter-preserving anal fistula repair using a novel radial emitting laser probe. Tech Coloproctol. 2011 Dec;15(4):445-49. doi: 10.1007/s10151-011-0726-0
  43. Giamundo P, Geraci M, Tibaldi L, Valente M. Closure of fistula-in-ano with laser--FiLaC: an effective novel sphincter-saving procedure for complex disease. Colorectal Dis. 2014 Feb;16(2):110-15. doi: 10.1111/codi.12440
  44. Meinero P, Mori L. Video-assisted anal fistula treatment (VAAFT): a novel sphincter-saving procedure for treating complex anal fistulas. Tech Coloproctol. 2011 Dec;15(4):417-22. doi: 10.1007/s10151-011-0769-2
  45. Garcia-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J, De-La-Quintana P, Garcia-Arranz M, Pascual M. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum. 2009 Jan;52(1):79-86. doi: 10.1007/DCR.0b013e3181973487
  46. Herreros MD, Garcia-Arranz M, Guadalajara H, De-La-Quintana P, Garcia-Olmo D. Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula Advanced Therapy Trial 1) and long-term evaluation. Dis Colon Rectum. 2012 Jul;55(7):762-72. doi: 10.1097/DCR.0b013e318255364a
  47. Mizushima T, Takahashi H, Takeyama H, Naito A, Haraguchi N, Uemura M, Nishimura J, Hata T, Takemasa I, Yamamoto H, Doki Y, Mori M. A clinical trial of autologous adipose-derived regenerative cell transplantation for a postoperative enterocutaneous fistula. Surg Today. 2016 Jul;46(7):835-42. doi: 10.1007/s00595-015-1246-8
  48. Raslan MM, Ayoub MA. Autologous bone marrow derived stem cells in the treatment of complex anal fistula. Int Surg J. 2018;5(6):2049-53. doi: 10.18203/2349-2902.isj20181840
  49. Xu Y, Liang S, Tang W. Meta-analysis of randomized clinical trials comparing fistulectomy versus fistulotomy for low anal fistula. Springerplus. 2016 Oct 6;5(1):1722. eCollection 2016. doi: 10.1186/s40064-016-3406-8
  50. Whiteford MH, Kilkenny J 3rd, Hyman N, Buie WD, Cohen J, Orsay C, Dunn G, Perry WB, Ellis CN, Rakinic J, Gregorcyk S, Shellito P, Nelson R, Tjandra JJ, Newstead G. Practice parameters for the treatment of perianal abscess and fistula-in-ano (revised). Dis Colon Rectum. 2005 Jul;48(7):1337-42. doi: 10.1007/s10350-005-0055-3
  51. Subhas G, Singh Bhullar J, Al-Omari A, Unawane A, Mittal VK, Pearlman R. Setons in the treatment of anal fistula: review of variations in materials and techniques. Dig Surg. 2012;29(4):292-300. doi: 10.1159/000342398
  52. Patton V, Chen CM, Lubowski D. Long-term results of the cutting seton for high anal fistula. ANZ J Surg. 2015 Oct;85(10):720-27. doi: 10.1111/ans.13156
  53. Shelygin JuA. Koloproktologija. Klinicheskie rekomendacii. Moscow, RF: GJeOTAR-Media; 2015. 528 p.
  54. Bakhtawar N, Usman M. Factors increasing the risk of recurrence in fistula-in-ano. Cureus. 2019 Mar 7;11(3):e4200. doi: 10.7759/cureus.4200
Address for correspondence:
61022, Ukraine, Kharkov,
Nauki av., 4
Kharkov National Medical University
of the Ministry of Health of Ukraine,
the Surgery Department No2,
tel.: +38-050-301-90-90,
Kryvoruchko Igor A.
Information about the authors:
Kryvoruchko IgorA., MD, Professor, Head of the Surgery Department No2, Kharkov National Medical University of the Ministry of Health of Ukraine, Kharkov, Ukraine.
Firsyk Tetiana M., Post-Graduate Student of the Surgery Departmet No2, Kharkov National Medical University of the Ministry of Health of Ukraine, Kharkov, Ukraine.



I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow,
The Russian Federation

Postoperative effusion in the pericardium, which is also defined as postpericardial syndrome, is a common complication after open heart surgery. This condition directly affects the duration of hospitalization and the costs spent on treatment, and can also lead to life-threatening complications. Postoperative effusion in the pericardium can vary from slight (66-84%) to severe, defined as a cardiac tamponade (2.6%). The aim of this review is to consider etiopathogenesis, major risk factors, prevention and treatment of postoperative pericardial effusion. The development of cardiac tamponade is directly correlated with the type of intervention: 1.3% after coronary artery bypass graft, 6.6% after 1 valve replacement, 4.3% after several valves replacement, 2.5% after combined valve replacement and coronary artery bypass graft, 9.3% after thoracic aorta surgeries. The highest risk for developing cardiac tamponade accompanies patients after heart transplantation, interventions on the thoracic aorta and mechanical valve prosthetics. A proven and effective drug treatment strategy for the postoperative pericardial effusion syndrome is a combination of NSAIDs and colchicine. The posterior pericardiotomy is an effective and safe method for the prevention of this complication, and the most priority way to treat cardiac tamponade is echocardiographically controlled pericardiocentesis.

Keywords: postoperative pericardial effusion, postpericardiotomy syndrome, cardiac tamponade, posterior pericardiotomy, pericardiocentesis
p. 577-590 of the original issue
  1. Khan NK, Järvelä KM, Loisa EL, Sutinen JA, Laurikka JO, Khan JA. Incidence, presentation and risk factors of late postoperative pericardial effusions requiring invasive treatment after cardiac surgery. Interact Cardiovasc Thorac Surg. 2017 Jun 1;24(6):835-40. doi: 10.1093/icvts/ivx011
  2. Leiva EH, Carreño M, Bucheli FR, Bonfanti AC, Umaña JP, Dennis RJ. Factors associated with delayed cardiac tamponade after cardiac surgery. Ann Card Anaesth. 2018 Apr-Jun;21(2):158-166. doi: 10.4103/aca.ACA_147_17
  3. Sasse T, Eriksson U. Post-cardiac injury syndrome: aetiology, diagnosis, and treatment. E-Journal of Cardiology Practice [Electronic resource]. 2017; 15(21) [cited 2017 Oct 31]. Available from:
  4. Imazio M, Hoit B. Post-cardiac injury syndromes. An emerging cause of pericardial diseases. Int J Cardiol. 2013 Sep 30;168(2):648-52. doi: 10.1016/j.ijcard.2012.09.052
  5. Nomura Y, Yoshinaga M, Haraguchi T, Oku S, Noda T, Miyata K, Umebayashi Y, Taira A. Relationship between the degree of injury at operation and the change in antimyosin antibody titer in the postpericardiotomy syndrome. Pediatr Cardiol. 1994 May-Jun;15(3):116-20. doi: 10.1007/BF00796322
  6. Gouriet F, Levy PY, Casalta JP, Zandotti C, Collart F, Lepidi H, Cautela J, Bonnet JL, Thuny F, Habib G, Raoult D. Etiology of Pericarditis in a Prospective Cohort of 1162 Cases. Am J Med. 2015 Jul;128(7):784.e1-8. doi: 10.1016/j.amjmed.2015.01.040
  7. Mangi AA, Palacios IF, Torchiana DF. Catheter pericardiocentesis for delayed tamponade after cardiac valve operation. Ann Thorac Surg. 2002 May;73(5):1479-83. doi: 10.1016/s0003-4975(02)03495-1
  8. Alraies MC, AlJaroudi W, Shabrang C, Yarmohammadi H, Klein AL, Tamarappoo BK. Clinical features associated with adverse events in patients with post-pericardiotomy syndrome following cardiac surgery. Am J Cardiol. 2014 Nov 1;114(9):1426-30. doi: 10.1016/j.amjcard.2014.07.078
  9. Shabetai R. Pericardial effusion: haemodynamic spectrum. Heart. 2004 Mar;90(3):255-56. doi: 10.1136/hrt.2003.024810
  10. Sagristà-Sauleda J, Angel J, Permanyer-Miralda G, Soler-Soler J. Long-term follow-up of idiopathic chronic pericardial effusion. N Engl J Med. 1999 Dec 30;341(27):2054-59. doi: 10.1056/NEJM199912303412704
  11. Reddy PS, Curtiss EI, Uretsky BF. Spectrum of hemodynamic changes in cardiac tamponade. Am J Cardiol. 1990 Dec 15;66(20):1487-91. doi: 10.1016/0002-9149(90)90540-h
  12. Adrichem R, Le Cessie S, Hazekamp MG, Van Dam NAM, Blom NA, Rammeloo LAJ, Filippini LHPM, Kuipers IM, Ten Harkel ADJ, Roest AAW. Risk of clinically relevant pericardial effusion after pediatric cardiac surgery. Pediatr Cardiol. 2019 Mar;40(3):585-94. doi: 10.1007/s00246-018-2031-4
  13. Ashikhmina EA, Schaff HV, Sinak LJ, Li Z, Dearani JA, Suri RM, Park SJ, Orszulak TA, Sundt TM 3rd. Pericardial effusion after cardiac surgery: risk factors, patient profiles, and contemporary management. Ann Thorac Surg. 2010 Jan;89(1):112-18. doi: 10.1016/j.athoracsur.2009.09.026
  14. You SC, Shim CY, Hong GR, Kim D, Cho IJ, Lee S, Chang HJ, Ha JW, Chang BC, Chung N. Incidence, Predictors, and Clinical Outcomes of Postoperative Cardiac Tamponade in Patients Undergoing Heart Valve Surgery. PLoS One. 2016 Nov 17;11(11):e0165754. doi: 10.1371/journal.pone.0165754. eCollection 2016.
  15. Pompilio G, Filippini S, Agrifoglio M, Merati E, Lauri G, Salis S, Alamanni F, Parolari A. Determinants of pericardial drainage for cardiac tamponade following cardiac surgery. Eur J Cardiothorac Surg. 2011 May;39(5):e107-13. doi: 10.1016/j.ejcts.2010.12.021
  16. Price S, Prout J, Jaggar SI, Gibson DG, Pepper JR. Tamponade following cardiac surgery: terminology and echocardiography may both mislead. Eur J Cardiothorac Surg. 2004 Dec;26(6):1156-60. doi: 10.1016/j.ejcts.2004.08.020
  17. Yu Z, Kittleson M, Patel J, Liou F, Yabuno J, Piponniau L, Chang D, Czer L, Azarbal B, Esmailian F, Kobashigawa J. Moderate pericardial effusions after heart transplant: do they require proactive intervention? Transplantation. 2014 Jul 15;98(Is):427.
  18. Vandenberg BF, Mohanty PK, Craddock KJ, Barnhart G, Hanrahan J, Szentpetery S, Lower RR. Clinical significance of pericardial effusion after heart transplantation. J Heart Transplant. 1988 Mar-Apr;7(2):128-34.
  19. Hauptman PJ, Couper GS, Aranki SF, Kartashov A, Mudge GH Jr, Loh E. Pericardial effusions after cardiac transplantation. J Am Coll Cardiol. 1994 Jun;23(7):1625-29. doi: 10.1016/0735-1097(94)90666-1
  20. Eryilmaz S, Emiroglu O, Eyileten Z, Akar R, Yazicioglu L, Tasoz R, Kaya B, Uysalel A, Ucanok K, Corapcioglu T, Ozyurda U. Effect of posterior pericardial drainage on the incidence of pericardial effusion after ascending aortic surgery. J Thorac Cardiovasc Surg. 2006 Jul;132(1):27-31. doi: 10.1016/j.jtcvs.2006.01.049
  21. Floerchinger B, Camboni D, Schopka S, Kolat P, Hilker M, Schmid C. Delayed cardiac tamponade after open heart surgery is supplemental CT imaging reasonable? J Cardiothorac Surg. 2013 Jun 24;8:158. doi: 10.1186/1749-8090-8-158
  22. Kaya M, Iyigün T, Yazıcı P, Melek Y, Göde S, Güler S, Karaçalılar M, Satılmışoğlu MH, Erek E. The effects of posterior pericardiotomy on pericardial effusion, tamponade, and atrial fibrillation after coronary artery surgery. Kardiochir Torakochirurgia Pol. 2014 Jun;11(2):113-18. doi: 10.5114/kitp.2014.43835
  23. Haqzad Y, Loubani M, Shah S. Short and long-term outcomes of re-exploration for bleeding/tamponade in CABG patients: up to 18 years follow up. SCTS Annual Meeting [Electronic resource]. 2018: Poster 112. Available from:
  24. Malouf JF, Alam S, Gharzeddine W, Stefadouros MA. The role of anticoagulation in the development of pericardial effusion and late tamponade after cardiac surgery. Eur Heart J. 1993 Nov;14(11):1451-57. doi: 10.1093/eurheartj/14.11.1451
  25. Watkin RW, Harper LV, Vernallis AB, Lang S, Lambert PA, Ranasinghe AM, Elliott TS. Pro-inflammatory cytokines IL6, TNF-alpha, IL1beta, procalcitonin, lipopolysaccharide binding protein and C-reactive protein in infective endocarditis. J Infect. 2007 Sep;55(3):220-25. doi: 10.1016/j.jinf.2007.05.174
  26. Regueiro A, Falces C, Cervera C, Del Rio A, Paré JC, Mestres CA,Castañeda X, Pericàs JM, Azqueta M, Marco F, Ninot S, Almela M, Moreno A, Miró JM. Risk factors for pericardial effusion in native valve infective endocarditis and its influence on outcome. Am J Cardiol. 2013 Sep 23;112(10):1646-51. 10.1016/j.amjcard.2013.07.024
  27. Maesen B, Nijs J, Maessen J, Allessie M, Schotten U. Post-operative atrial fibrillation: a maze of mechanisms. Europace. 2012 Feb;14(2):159-74. doi: 10.1093/europace/eur208
  28. Siliato-Robles MS, Gracia-Baena JM, Sureda-Barbosa JC, Igual-Barceló A. Delayed cardiac tamponade after catheter ablation therapy due to a Valsalva manoeuvre. Eur J Cardiothorac Surg. 2019 Feb 1;55(2):369-70. doi: 10.1093/ejcts/ezy232
  29. Dalili M, Zamani H, Aarabi-Moghaddam M. Pericardial effusion after pediatric cardiac surgeries: a single center observation. Res Cardiovasc Med. 2012 Nov;1(1):28-32. doi: 10.5812/cardiovascmed.4601
  30. Khandaker MH, Espinosa RE, Nishimura RA, Sinak LJ, Hayes SN, Melduni RM, Oh JK. Pericardial disease: diagnosis and management. Mayo Clin Proc. 2010 Jun;85(6):572-93. doi: 10.4065/mcp.2010.0046
  31. Meurin P, Tabet JY, Thabut G, Cristofini P, Farrokhi T, Fischbach M, Pierre B, Driss AB, Renaud N, Iliou MC, Weber H. Nonsteroidal anti-inflammatory drug treatment for postoperative pericardial effusion: a multicenter randomized, double-blind trial. Ann Intern Med. 2010 Feb 2;152(3):137-43. doi: 10.7326/0003-4819-152-3-201002020-00004
  32. Horneffer PJ, Miller RH, Pearson TA, Rykiel MF, Reitz BA, Gardner TJ. The effective treatment of postpericardiotomy syndrome after cardiac operations. A randomized placebo-controlled trial. J Thorac Cardiovasc Surg. 1990 Aug;100(2):292-96.
  33. Imazio M, Bobbio M, Cecchi E, Demarie D, Demichelis B, Pomari F, Moratti M, Gaschino G, Giammaria M, Ghisio A, Belli R, Trinchero R. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation. 2005 Sep 27;112(13):2012-16. doi: 10.1161/CIRCULATIONAHA.105.542738
    354 Melvan JN, Madden D, Vasquez JC, DeLaRosa J. Computed Tomography-guided Pericardiocentesis: An alternative approach for accessing the pericardium. Heart Lung Circ. 2016 Jul;25(7):725-28. doi: 10.1016/j.hlc.2016.01.004
  34. Çelik S, Lestuzzi C, Cervesato E, Dequanter D, Piotti P, De Biasio M, Imazio M. Systemic chemotherapy in combination with pericardial window has better outcomes in malignant pericardial effusions. J Thorac Cardiovasc Surg. 2014 Nov;148(5):2288-93. doi: 10.1016/j.jtcvs.2014.04.031
  35. Izadi Amoli A, Bozorgi A, HajHossein Talasaz A, Salehi Omran A, Mortazavi SH, Jalali A, Nasirpour S, Jenab Y. Efficacy of colchicine versus placebo for the treatment of pericardial effusion after open-heart surgery: A randomized, placebo-controlled trial. Am Heart J. 2015 Dec;170(6):1195-201. doi: 10.1016/j.ahj.2015.09.020
  36. Maisch B, Ristić AD. Practical aspects of the management of pericardial disease. Heart. 2003 Sep;89(9):1096-103. doi: 10.1136/heart.89.9.1096
  37. Gozdek M, Pawliszak W, Hagner W, Zalewski P, Kowalewski J, Paparella D, Carrel T, Anisimowicz L, Kowalewski M. Systematic review and meta-analysis of randomized controlled trials assessing safety and efficacy of posterior pericardial drainage in patients undergoing heart surgery. J Thorac Cardiovasc Surg. 2017 Apr;153(4):865-875.e12. doi: 10.1016/j.jtcvs.2016.11.057
  38. Kaleda VI, McCormack DJ, Shipolini AR. Does posterior pericardiotomy reduce the incidence of atrial fibrillation after coronary artery bypass grafting surgery? Interact Cardiovasc Thorac Surg. 2012 Apr;14(4):384-89. doi: 10.1093/icvts/ivr099
  39. Crystal E, Garfinkle MS, Connolly SS, Ginger TT, Sleik K, Yusuf SS. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003611. doi: 10.1002/14651858.CD003611.pub2
  40. Creswell LL, Alexander JC Jr, Ferguson TB Jr, Lisbon A, Fleisher LA; American College of Chest Physicians. Intraoperative interventions: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest. 2005 Aug;128(2 Suppl):28S-35S. doi: 10.1378/chest.128.2_suppl.28s
  41. Dunning J, Treasure T, Versteegh M, Nashef SA; EACTS Audit and Guidelines Committee. Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery. Eur J Cardiothorac Surg. 2006 Dec;30(6):852-72. doi: 10.1016/j.ejcts.2006.09.003
  42. Farsak B, Günaydin S, Tokmakoğlu H, Kandemir Ö, Yorgancioğlu C, Zorlutuna Y. Posterior pericardiotomy reduces the incidence of supra-ventricular arrhythmias and pericardial effusion after coronary artery bypass grafting. Eur Cardiothorac Surg. 2002 Aug;22(Is 2):278-81. doi: 10.1016/S1010-7940(02)00259-2
  43. Haddadzadeh M, Motavaselian M, Rahimianfar AA, Forouzannia SK, Emami M, Barzegar K. The effect of posterior pericardiotomy on pericardial effusion and atrial fibrillation after off-pump coronary artery bypass graft. Acta Med Iran. 2015;53(1):57-61.
  44. Mulay A, Kirk AJ, Angelini GD, Wisheart JD, Hutter JA. Posterior pericardiotomy reduces the incidence of supra-ventricular arrhythmias following coronary artery bypass surgery. Eur J Cardiothorac Surg. 1995;9(3):150-52. doi: 10.1016/s1010-7940(05)80063-6
  45. Callahan JA, Seward JB, Nishimura RA, Miller FA Jr, Reeder GS, Shub C, Callahan MJ, Schattenberg TT, Tajik AJ. Two-dimensional echocardiographically guided pericardiocentesis: experience in 117 consecutive patients. Am J Cardiol. 1985 Feb 1;55(4):476-79. doi: 10.1016/0002-9149(85)90397-2
  46. Martin R, Rakowski H, French J, Popp R. Localization of pericardial effusion with wide angle phased array echocardiography. Am J Cardiol. 1978 Dec;42(6):904-12. doi: 10.1016/0002-9149(78)90674-4
  47. Maggiolini S, Gentile G, Farina A, De Carlini CC, Lenatti L, Meles E, Achilli F, Tempesta A, Brucato A, Imazio M. Safety, efficacy, and complications of pericardiocentesis by real-time echo-monitored procedure. Am J Cardiol. 2016 Apr 15;117(8):1369-74. doi: 10.1016/j.amjcard.2016.01.043
  48. Tsang TS, Enriquez-Sarano M, Freeman WK, Barnes ME, Sinak LJ, Gersh BJ, Bailey KR, Seward JB. Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21 years. Mayo Clin Proc. 2002 May;77(5):429-36. doi: 10.4065/77.5.429
  49. Neves D, Silva G, Morais G, Ferreira N, Carvalho M, Gama Ribeiro V, Bettencourt N. Computed tomography-guided pericardiocentesis - A single-center experience. Rev Port Cardiol. 2016 May;35(5):285-90. doi: 10.1016/j.repc.2015.11.015
  50. Bruning R, Muehlstaedt M, Becker C, Knez A, Haberl R, Reiser M. Computed tomography-fluoroscopy guided drainage of pericardial effusions: experience in 11 cases. Invest Radiol. 2002 Jun;37(6):328-32. doi: 10.1097/00004424-200206000-00004
  51. Tam A, Ensor JE, Snyder H, Gupta S, Durand JB, Wallace MJ. Image-guided drainage of pericardial effusions in oncology patients. Cardiovasc Intervent Radiol. 2009 Nov;32(6):1217-26. doi: 10.1007/s00270-009-9594-7
  52. Alp I, Ugur M, Selcuk I, Ulucan AE, Temizkan V, Yilmaz AT. Safety Pericardiocentesis with Fluoroscopy Following Cardiac Surgery. Ann Thorac Cardiovasc Surg. 2019 Jun 20;25(3):158-63. doi: 10.5761/atcs.oa.18-00188
  53. Refat A, Abdelsayed A. Does the position of the drains after open heart surgery make a difference? A clinical randomized trial. J Egyp Soc CardioThorac Surg. 2018 Dec;26(4):281-86. doi: 10.1016/j.jescts.2018.10.002
Address for correspondence:
119435, Russian Federation,
Moscow, Bolshaya Pirogovskaya str., 6-1,
I.M. Sechenov First Moscow
State Medical University,
the Faculty Surgery Department No1,
tel. +7 926 816-47-37,
Danachev Alexander O.
Information about the authors:
Komarov Roman N., MD, Head of the Faculty Surgery Department No1, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
Kurasov Nikolay O., Assistant of the Faculty Surgery Dpartment No1, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
Ismailbaev Alisher M., PhD, Assistant of the Faculty Surgery Department No1, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
Danachev Alexander O., the Three-Year Post-Graduate Student, the Faculty Surgery Department No1, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.




E.A.Vagner Perm State Medical University 1,
Perm Regional Clinical Hospitall 2, Perm,
The Russian Federation

Over the last decade laparoscopic sleeve gastrectomy has taken a leading position among bariatric operations. The failure of the mechanical suture of the gastric stump is considered to be the most severe complication in the postoperative period. The purpose of this report is to demonstrate a case of successful treatment of the late leakage of the gastric sleeve staple line with interventional methods. A 56-year-old patient with a body mass index of 50 underwent laparoscopic sleeve gastrectomy using a 36 Fr calibration probe. Check of the mechanical staple line for leak-tightness was carried out by the introduction of 150 ml of liquid colored methylene blue. On the 12th day after the operation computed tomography revealed suture incompetence. X-ray stomach examination was conducted twice, it was impossible to detect swelling of the contrast agent. To close the site of leakage, a fully covered self-expanding stent was installed endoscopically, and the zone of abscess was drained by relaparoscopy. When the stent removed below the cardiac pulp, it was reinstalled. After 4 weeks the fistula closed, and no swelling was detected on CT. The stent was removed and the patient was discharged from hospital in satisfactory condition.

Keywords: laparoscopic sleeve gastrectomy, leakage, self-expanding stent
p. 591-596 of the original issue
  1. Obesity / WHO [Internet]. Accessed April 2013. Available from:
  2. Dedov II, Melnichenko GA, Shestakova MV, Troshina EA, Mazurina NV, Shestakova EA, Yashkov YuI, Neimark AE, Birykova EV, Bondarenko IZ, Bordan NS, Dzgoeva FH, Ershova EV, Komshilova KA, Mkrtumyan AM, Petunina NA, Romantsova TI, Starostina EG, Strongin LG, Suplotova LA, Fadeev VV. Russian national clinical recommendations for morbid obesity treatment in adults. 3rd revision Morbid obesity treatment in adults. Ozhirenie i Metabolizm. 2018;15(1):53-70. doi: 10.14341/OMET2018153-70 (In Russ.)
  3. Yashkov YuI, Sedletskiy YuI, Vasilevskiy DI, Krichmar AM. Revision procedures in bariatric surgery. Pediatr. 2019;10(3): 81-91. (In Russ.)
  4. Welbourn R, Hollyman M, Kinsman R, Dixon J, Liem R, Ottosson J, Ramos A, Väge V, Al-Sabah S, Brown W, Cohen R, Walton P, Himpens J. Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg. 2019 Mar;29(3):782-95. doi: 10.1007/s11695-018-3593-1
  5. Zvirkun VV, Mosin SV, Askerkhanov RG, Feidorov IYU, Petrova AL, Izrailov RG, Kulezneva YUV, Khatkov IE. The case of a surgical treatment of patient with chronic leak after sleeve gastrectomy with two-step double-tract reconstruction. Hirurgija Zhurn im NI Pirogova. 2018;(6):115-19. (In Russ.)
  6. Dakwar A, Assalia A, Khamaysi I, Kluger Y, Mahajna A. Late complication of laparoscopic sleeve gastrectomy. Case Rep Gastrointest Med. 2013;2013:136153. doi: 10.1155/2013/136153
  7. Jammah AA. Endocrine and metabolic complications after bariatric surgery. Saudi J Gastroenterol. 2015 Sep-Oct;21(5):269-77. doi: 10.4103/1319-3767.164183
  8. Praveenraj P, Gomes RM, Kumar S, Senthilnathan P, Parthasarathi R, Rajapandian S, Palanivelu C. Management of gastric leaks after laparoscopic sleeve gastrectomy for morbid obesity: A tertiary care experience and design of a management algorithm. J Minim Access Surg. 2016 Oct-Dec;12(4):342-49. doi: 10.4103/0972-9941.181285
  9. Glinnik AA, Stebunov SS, Bogushevich OS, Rummo OO, Avlas SD, Minov AF. Nesostojatelnost linii mehanicheskogo shva posle rukavnoj rezekcii zheludka. Evrazijskij Sojuz Uchenyh. 2019;(4 ch 4):6162-69. doi: 10.31618/ESU. 2413-9335.2019.4.61.29 (In Russ.)
  10. Yashkov YI, Lutsevich , Bordan NS, Ivleva OV. Efficiency of laparoscopic sleeve gastrectomy in patients with obesity. Ozhirenie i Metabolizm. 2015;12(1):20-28. (In Russ.)
  11. Todurov IM, Pleguca AI, Perehrestenko AV, Kalashnikov AA, Kosjuhno SV. Sleeve gastrectomy in patients with obesity. Morfologija. 2017;11(4):53-58. (In Russ.)
  12. Schwarz J, Strobl FF, Paprottka PM, DAnastasi M, Spelsberg FW, Rentsch M, Reiser M, Trumm CG. CT fluoroscopy-guided drain placement to treat infected gastric leakage after sleeve gastrectomy: technical and clinical outcome of 31 procedures. Rofo. 2020 Feb;192(2):163-70. doi: 10.1055/a-0977-3496
  13. El-Sayes IA, Frenken M, Weiner RA. Management of leakage and stenosis after sleeve gastrectomy. Surgery. 2017 Sep;162(3):652-661. doi: 10.1016/j.surg.2017.04.015
Address for correspondence:
614000, Russian Federation,
Perm, Kuybyshev str., 43,
E.A. Vagner Perm State Medical University,
the Surgery Department with the Course
of the Cardiovascular Surgery
and Invasive Cardiology,
tel.: +7902 83 569 65,
Kotelnikova Ludmila P.
Information about the authors:
Kotelnikova Liudmila P., MD, Professor, Head of the Surgery Department with the Course of the Cardiovascular Surgery and Invasive Cardiology, E.A.Vagner Perm State Medical University, Perm, Russian Federation.
Fedachuk Alexey N., PhD, Surgeon of the 1st Surgical Unit, Perm Regional Clinical Hospital, Perm, Russian Federation.
Sharev Andrey V., Endoscopist, Head of the Endoscopy Unit, Perm Regional Clinical Hospital, Perm, Russian Federation



Sumy State University 1,
Utility Non-Profit Enterprise Clinical Hospital No5 of Sumy Municipal Council 2, Sumy,

Gastrointestinal stromal tumors (GIST) are one of the most common mesenchymal tumors that originate from the intestinal cells of Cajal. The most common localization of GIST is the gastrointestinal tract, however, extragastrointestinal forms are sometimes found. Most GISTs are small in size, which most often does not exceed 5 - 8 cm in maximum dimension. This article describes the case of a patient with a non-metastatic giant tumor of the stomach without any clinical manifestations. The tumor was localized in the abdominal cavity, occupying almost all of it, squeezing and displacing the surrounding organs. Due to the cystic-solid structure, its gigantic size and intimate adherence to the surrounding organs, it was not possible to carry out an accurate differential diagnosis before surgery. Intraoperative imaging of the tumor, further histological and immunohistochemical (CD117, CD34, S100, CD45, PanCK; Ki-67) studies made possible to establish the diagnosis of gastric GIST T4N0M0 stage II. Based on the data obtained, despite the gigantic size, the prognosis of the disease was considered favorable (low mitotic index, no metastasis). During the period of clinical observation, within 1.5 years after surgery, no relapse or disease progression was recorded, which indicates a favorable prognosis for the patient.

Keywords: gastric tumor, gastrointestinal stromal tumor, giant tumor, operative treatment
p. 597-602 of the original issue
  1. Romaniuk , Lyndin M, Smiyanov V, Sikora V, Rieznik A, Kuzenko Y, Budko H, Moskalenko Y, Karpenko L, Sikora V, Gladchenko O. Primary multiple tumor with affection of the thyroid gland, uterus, urinary bladder, mammary gland and other organs. Pathol Res Pract. 2017 May;213(5):574-79. doi: 10.1016/j.prp.2017.01.003
  2. Corless CL, Heinrich MC. Molecular pathobiology of gastrointestinal stromal sarcomas. Annu Rev Pathol. 2008;3:557-86. doi: 10.1146/annurev.pathmechdis.3.121806.151538
  3. Joensuu H, Hohenberger P, Corless CL. Gastrointestinal stromal tumour. Lancet. 2013 Sep 14;382(9896):973-83. doi: 10.1016/S0140-6736(13)60106-3
  4. Laurini JA, Carter JE. Gastrointestinal stromal tumors: a review of the literature. Arch Pathol Lab Med. 2010 Jan;134(1):134-41. doi: 10.1043/2008-0083-RSR2.1
  5. Miettinen M, Lasota J. Gastrointestinal stromal tumors definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 2001 Jan;438(1):1-12. doi: 10.1007/s004280000338
  6. Obinero C, Makar GS, Rowe JS, Makar MS, Holdbrook T, Hageboutros A, Spitz FR, Kovacs JE. Large incidental gastrointestinal stromal tumors in a patient presenting with acutely symptomatic nephrolithiasis: A case report. Radiol Case Rep. 2019 Feb 26;14(5):555-60. doi: 10.1016/j.radcr.2019.02.005. eCollection 2019 May.
  7. Sahu KK, Tapadia R, Kini JR, Pai RR, Kini H, Nirupama M, Pooja KS. Discovered on gastrointestinal stromal tumor 1, a keystone in the diagnosis of extraintestinal gastrointestinal stromal tumors. J Cancer Res Ther. 2019 Jan-Mar;15(1):138-41. doi: 10.4103/jcrt.JCRT_28_17
  8. Alghamdi HM, Amr SS, Shawarby MA, Sheikh SS, Alsayyah AA, Alamri AM, Ismail MH, Almarhabi A, Alrefaee MA, Ahmed MI. Gastrointestinal stromal tumors. A clinicopathological study. Saudi Med J. 2019 Feb;40(2):126-30. doi: 10.15537/smj.2019.2.23913
  9. Etherington MS, DeMatteo RP. Tailored management of primary gastrointestinal stromal tumors. Cancer. 2019 Apr 1. doi: 10.1002/cncr.32067
  10. Wang Y, Call J. Mutational Testing in Gastrointestinal Stromal Tumor. Curr Cancer Drug Targets. 2019;19(9):688-697. doi: 10.2174/1568009619666190326123945
  11. Parab TM, DeRogatis MJ, Boaz AM, Grasso SA, Issack PS, Duarte DA, Urayeneza O, Vahdat S, Qiao JH, Hinika G. Gastrointestinal stromal tumors: a comprehensive review. J Gastrointest Oncol. 2019 Feb;10(1):144-54. doi: 10.21037/jgo.2018.08.20
  12. Iwatsuki M, Harada K, Iwagami S, Eto K, Ishimoto T, Baba Y, Yoshida N, Ajani JA, Baba H. Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors. Ann Gastroenterol Surg. 2018 Sep 27;3(1):43-49. doi: 10.1002/ags3.12211. eCollection 2019 Jan.
  13. Romaniuk A, Lyndin M, Sikora V, Lyndina Y, Panasovska K. Histological and immunohistochemical features of medullary breast cancer. Folia Med Cracov. 2015;55(2):41-48.
  14. Gastrointestinal Stromal Tumors Treatment (PDQⓇ)Health Professional Version [Internet]. Available from:
Address for correspondence:
40022, Ukraine,
Sumy, Privokzalnaya str., 31,
Medical Institute of Sumy State
Medical University, the Department
of Oncology and Radiology,
tel.: +38 095 8 000 489,
Smorodska Olga N.
Information about the authors:
Vynnychenko Ihor A., PhD, Associate Professor, Head of the Department of Oncology and Radiology, Medical Institute of Sumy State Medical University, Sumy, Ukraine.
Kononenko Mykola G., MD, Professor of the Surgery Department, Medical Institute of Sumy State Medical University, Sumy, Ukraine.
Smorodska Olga N., Post-Graduate Student of the Department of Oncology and Radiology, Medical Institute of Sumy State Medical University, Surgeon, Clinical Hospital No5, Sumy, Ukraine.
Ivanov StanislavS., Surgeon, Clinical Hospital No5, Sumy, Ukraine.
MoskalenkoYuliia V., PhD, Assistant of the Department of Oncology and Radiology, Medical Institute of Sumy State Medical University, Sumy, Ukraine.
Vynnychenko Oleksandr I., PhD, Assistant of the Department of Oncology and Radiology, Medical Institute of Sumy State Medical University, Sumy, Ukraine.
Sikora Vladyslav V., PhD, Assistant of the Pathologic Anatomy Department, Medical Institute of Sumy State Medical University, Sumy, Ukraine.
Lyndin Mykola S., PhD, Assistant of the Pathologic Anatomy Department, Medical Institute of Sumy State Medical University, Sumy, Ukraine.
Romaniuk Anatolii N., MD, Professor, Head of the Pathologic Anatomy Department, Medical Institute of Sumy State Medical University, Sumy, Ukraine.
Contacts | ©Vitebsk State Medical University, 2007-2023